Skip to main content

Icon Legend
Presentation Icons
Event Add-on
Event Add-on
In Person Only
In Person Only
Off-site Event
Off-site Event
Location: Marriott Marquis
Location: Marriott Marquis

Posters

Posters

  • Monday, September 30, 2024
  • 8:00 AM - 9:00 AM ET
    3469 - Association between Neurodevelopment and Neurocognitive Outcomes: A Multi-Trajectory Analysis in Childhood Brain Tumor Survivors
    Location: Hall C
    Presenter: Elizabeth Olatunji, BS, MPhil – Johns Hopkins Medicine
  • 8:00 AM - 9:00 AM ET
    3470 - Dosimetric Outcomes with the Addition of Interstitial Needles in HDR Brachytherapy for Non-Bulky Cervical Tumors
    Location: Hall C
    Presenter: Scarlett Acklin, MD – Duke University
  • 8:00 AM - 9:00 AM ET
    3471 - Radiation Oncology Provider Perceptions and Attitudes Towards Virtual Tumor Boards: Is Quality Maintained and Does Virtual Format Improve Work-Life Balance?
    Location: Hall C
    Presenter: Matt Adams, BS – Lake Erie College of Osteopathic Medicine
  • 8:00 AM - 9:00 AM ET
    3472 - A Cross Sectional Analysis of Radiation Oncology Presence on Tiktok
    Location: Hall C
    Presenter: Rimsha Afzal, BS – Kentucky College of Osteopathic Medicine
  • 8:00 AM - 9:00 AM ET
    3473 - Radiate & Educate: Empowering Future Physicians through an International Radiation Oncology Student Newsletter
    Location: Hall C
    Presenter: Anthony Alanis, BS – University of Texas Rio Grande Valley School of Medicine
  • 8:00 AM - 9:00 AM ET
    3474 - Research Match: Connecting Researchers to Projects
    Location: Hall C
    Presenter: James Alin, BS – Medical College of Georgia
  • 8:00 AM - 9:00 AM ET
    3475 - Quality of Life in Cervical Cancer Survivors Treated with Chemoradiotherapy: A Systematic Review
    Location: Hall C
    Presenter: Isabela Anawate, BA – University of Texas Southwestern Medical Center
  • 8:00 AM - 9:00 AM ET
    3476 - Standardizing Research Training in Radiation Oncology Residency: A Pilot Program Evaluation
    Location: Hall C
    Presenter: Rojine Ariani, MD, MS – UCLA David Geffen School of Medicine/UCLA Medical Center
  • 8:00 AM - 9:00 AM ET
    3477 - Evaluating the Impact of Bowel Gas Variations for Wilms Tumor in Pediatric Proton Therapy
    Location: Hall C
    Presenter: Ozgur Ates, PhD – St. Jude Children's Research Hospital
  • 8:00 AM - 9:00 AM ET
    3478 - Transforming into a Trauma-Informed Care Radiation Oncology Department: Training Program Design, Execution and Evaluation of our Programs Impact
    Location: Hall C
    Presenter: Courtney Misher, RT, BS, MPH – Penn Medicine
  • 8:00 AM - 9:00 AM ET
    3479 - Adjuvant Chemotherapy with High-Dose-Rate Vaginal Cuff Brachytherapy Alone vs. Chemotherapy with Pelvic Radiation (with or without Brachytherapy) in Locally Advanced Endometrial Cancer: Single Institu
    Location: Hall C
    Presenter: Mustafa Basree, DO, MS – University of Wisconsin Hospitals and Clinics
  • 8:00 AM - 9:00 AM ET
    3480 - The Comparison of Vaginal Cuff Brachytherapy and External Pelvic Radiotherapy in Stage IB Grade 3 Endometrial Cancer
    Location: Hall C
    Presenter: Ferah Yildiz, MD – Hacettepe University Medical School
  • 8:00 AM - 9:00 AM ET
    3481 - Funded Radiation Oncology Visiting Medical Student Electives: A Cross-Sectional Analysis
    Location: Hall C
    Presenter: Colin McNamara, MSN – Dartmouth Geisel School of Medicine
  • 8:00 AM - 9:00 AM ET
    3482 - Long-Term Outcomes following Proton Therapy for Pediatric Spinal Low-Grade Glioma
    Location: Hall C
    Presenter: Ryan Brisson, MD – University of Florida
  • 8:00 AM - 9:00 AM ET
    3483 - Radiation Oncology Hands-on Undergraduate Teaching: Digital Cross Sectional Anatomy and Tumor Pathology in CT, MRI and PET
    Location: Hall C
    Presenter: Thomas Brunner, MD – Medical University Graz
  • 8:00 AM - 9:00 AM ET
    3484 - Pretreatment Risk Factors for Cervical Cancer Recurrence: Examining Potential Indications for Treatment Intensification
    Location: Hall C
    Presenter: Santino Butler, MD – Stanford University School of Medicine
  • 8:00 AM - 9:00 AM ET
    3485 - Beyond the City Lights: Mapping the Rural Training Terrain for U.S. Radiation Oncology Residency Programs
    Location: Hall C
    Presenter: Vincent Cassidy, MD, MBA – University of Florida
  • 8:00 AM - 9:00 AM ET
    3486 - AI-Generated Image-Based Mnemonics: Enhancing Learning Efficiency in Radiation Oncology
    Location: Hall C
    Presenter: Basil Chaballout, MD – David Geffen School of Medicine at UCLA
  • 8:00 AM - 9:00 AM ET
    3487 - Impact of Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio on Definitive Treatment of Locally Advanced Cervical Cancer
    Location: Hall C
    Presenter: Yhana Chavis, DO – University of Virginia Health Systems
  • 8:00 AM - 9:00 AM ET
    3488 - Pilot Study of an Integrated Clinical and Didactic Interprofessional Curriculum on Breast Radiotherapy
    Location: Hall C
    Presenter: Jie Jane Chen, MD – University of California, San Francisco
  • 8:00 AM - 9:00 AM ET
    3489 - Efficacy of Concurrent Intensity Modulated Chemoradiotherapy Combined with Induction Chemotherapy or Adjuvant Chemotherapy in the Treatment of Locally Cervical Cancer with 2018FIGO Stage Correction
    Location: Hall C
    Presenter: Shaojun Chen, MD, MS, RT – Fourth Affiliated Hospital of Guangxi Medical University
  • 8:00 AM - 9:00 AM ET
    3490 - Digital vs. Human Scribes: Radiation Oncology Provider Perceptions and Attitudes
    Location: Hall C
    Presenter: Sylvia Choo, BA – University of South Florida College of Medicine
  • 8:00 AM - 9:00 AM ET
    3491 - Factors Associated with Stereotactic Body Radiotherapy Use in Oligometastatic Uterine Cancer and Implications for Survival
    Location: Hall C
    Presenter: Cheryl Claunch, MD, PhD – Baylor College of Medicine
  • 8:00 AM - 9:00 AM ET
    3492 - Patterns of Care and Clinical Outcomes for Pediatric Wilms Tumor Treated with Proton Therapy on the Multi-Institutional Pediatric Proton Consortium Registry
    Location: Hall C
    Presenter: Erron Collins, MD – WellStar Health System
  • 8:00 AM - 9:00 AM ET
    3493 - Template Based Transperineal Interstitial Brachytherapy for Gynecological Cancer: A Multi-Institutional Analysis of 319 Patients
    Location: Hall C
    Presenter: Ryan Davis, MD – City of Hope National Medical Center
  • 8:00 AM - 9:00 AM ET
    3494 - Characteristics of Radiation Oncology Residency Program Directors in 2023
    Location: Hall C
    Presenter: Sanjana Davuluri, BS, MHS – Rowan SOM
  • 8:00 AM - 9:00 AM ET
    3495 - Clinical Outcomes of Stage IVB Gynecologic Malignancies Treated with Definitive Radiotherapy
    Location: Hall C
    Presenter: Khaled Dibs, MD – The James Cancer Hospital & Solove Research Institute
  • 8:00 AM - 9:00 AM ET
    3496 - The Use of Stereotactic Body Radiation Therapy in the Management of Oligometastatic Disease in Uterine Cancer
    Location: Hall C
    Presenter: Baher Elgohari, MD, MS, MBBS – UPMC Hillman Cancer Center
  • 8:00 AM - 9:00 AM ET
    3497 - Adjuvant Treatment of Stage I-II Serous Endometrial Carcinoma: A Single Canadian Institutions 20-Year Retrospective Review
    Location: Hall C
  • 8:00 AM - 9:00 AM ET
    3498 - The Radiosurgery Society Mentored Publications: Advancing Guidance and Collaboration in Stereotactic Radiation Therapy while Enhancing Physician Wellness
    Location: Hall C
    Presenter: Fatemeh Fekrmandi, MD, MS – Roswell Park Comprehensive Cancer Center
  • 8:00 AM - 9:00 AM ET
    3499 - Treatment Patterns and Outcomes in Geriatric Women with Cervical Cancer
    Location: Hall C
    Presenter: Sarah Feldkamp, MD – University of Cincinnati
  • 8:00 AM - 9:00 AM ET
    3500 - Clinical Outcomes of Neuroendocrine Carcinoma of the Cervix: Retrospective Review from a Large Academic Cancer Center
    Location: Hall C
    Presenter: Jason Fernandes, MD – University of Toronto
  • 8:00 AM - 9:00 AM ET
    3501 - Radiation Oncology Patient Education: A Scoping Review to Identify Future Directions for Scholarship
    Location: Hall C
    Presenter: Kathryn Fink, BS – Northwestern Feinberg School of Medicine
  • 8:00 AM - 9:00 AM ET
    3502 - Craniospinal Irradiation with Proton Beams Comparing Irradiation Method for Pediatric Patients
    Location: Hall C
    Presenter: Nobuyoshi Fukumitsu, MD, PhD – Kobe Proton Center
  • 8:00 AM - 9:00 AM ET
    3503 - The Role of Adjuvant Radiotherapy and Chemotherapy for Surgically Staged Non-Myoinvasive Uterine Serous Carcinoma with Negative Peritoneal Washings
    Location: Hall C
    Presenter: Ahmed Ghanem, MD, PhD – Henry Ford Cancer Institute/Alexandria University
  • 8:00 AM - 9:00 AM ET
    3504 - Feasibility of Biology-Guided Radiotherapy for Tumors in the Cervix Using a PET-CT Linac
    Location: Hall C
    Presenter: Grant Gibbard, MS – RefleXion
  • 8:00 AM - 9:00 AM ET
    3505 - Long Term Proton Therapy Outcomes in the Reirradiation Setting for Recurrent Pediatric Ependymoma
    Location: Hall C
    Presenter: Gobind Gill, MD – University of Alabama at Birmingham
  • 8:00 AM - 9:00 AM ET
    3506 - Incidence and Dosimetric Characteristics Associated with Mandible Osteoradionecrosis in Pediatric Patients Treated with Proton Therapy for Head and Neck Malignancies
    Location: Hall C
    Presenter: Sage Copling, BS – MD Anderson Cancer Center
  • 8:00 AM - 9:00 AM ET
    3507 - Gavage of Limosilactobacillus reuteri Releasing IL-22 (LR-IL-22), the Tumor Microenvironment, and  Irradiation in Ovarian Cancer
    Location: Hall C
    Presenter: Diala Hamade, MD – University of Pittsburgh Medical Center
  • 8:00 AM - 9:00 AM ET
    3508 - Hypofractionated Pelvic Irradiation Followed by Image-Guided Brachytherapy in Women with Primary Gynecological Carcinoma or Oligometastatic Disease to Gynecological Tract: A New Paradigm of Care
    Location: Hall C
    Presenter: Diala Hamade, MD – University of Pittsburgh Medical Center
  • 8:00 AM - 9:00 AM ET
    3509 - Improving the Therapeutic Ratio in Parameningeal Rhabdomyosarcoma through the Use of LET-Optimized Proton Arc Therapy
    Location: Hall C
  • 8:00 AM - 9:00 AM ET
    3510 - Local Recurrence Rates following Equivocal 3-month Post-Treatment PET after High Dose Rate Brachytherapy for Locally Advanced Cervical Cancer: An Updated Cohort
    Location: Hall C
    Presenter: Emily Harris, MD – Duke Cancer Institute
  • 8:00 AM - 9:00 AM ET
    3511 - FDG-PET/CT Guided Bone Marrow Sparing: Should We Spare Marrow Volume or Marrow Load
    Location: Hall C
    Presenter: Dimitre Hristov, PhD – Stanford University
  • 8:00 AM - 9:00 AM ET
    3512 - Assessing Individuals Who Graduate from a U.S. Radiation Oncology Residency Program and Subsequently Pursued a Fellowship
    Location: Hall C
    Presenter: Kristin Hsieh, MD – Icahn School of Medicine at Mount Sinai
  • 8:00 AM - 9:00 AM ET
    3513 - Improved Toxicities with Volumetric Modulated Arc Therapy Compared to 2D Total Body Irradiation
    Location: Hall C
    Presenter: Nataliya Kovalchuk, PhD – Stanford Cancer Institute Palo Alto
  • 8:00 AM - 9:00 AM ET
    3514 - Prognostic Factors in H3K7M-Mutant Diffuse Midline Gliomas
    Location: Hall C
    Presenter: Samantha Induni – Georgetown University
  • 8:00 AM - 9:00 AM ET
    3515 - Re-Irradiation in Children with Recurrent Medulloblastoma
    Location: Hall C
    Presenter: Ayca Iribas, MD – Istanbul University
  • 8:00 AM - 9:00 AM ET
    3516 - Outcomes and Patterns of Failure for Women with FIGO Stage I-II Uterine Non-Endometroid Carcinoma after Surgical Staging, Adjuvant Chemotherapy and Vaginal Cuff Brachytherapy
    Location: Hall C
    Presenter: Yoonsun Jee, MD – Henry Ford Hospital-Henry Ford Cancer Institute
  • 8:00 AM - 9:00 AM ET
    3517 - Cervical Clear Cell Adenocarcinoma: Real-World Insights on Patient Profiles, Treatments and Comparative Efficacy of Locoregional Treatments
    Location: Hall C
    Presenter: Samyukta Jhavar – Baylor College of Medicine
  • 8:00 AM - 9:00 AM ET
    3518 - Systemic Immune-Inflammatory Index Predict Short-Term Outcome in Cervical Cancer Patients Treated with PD-1 Inhibitor
    Location: Hall C
    Presenter: Ruiqiu Zhu, MD, PhD – Soochow University
  • 8:00 AM - 9:00 AM ET
    3519 - Bulky Primary Thoracic Sarcomas in Children Treated with Preoperative Proton Radiotherapy
    Location: Hall C
    Presenter: Cecilia Jiang, MD – University of Pennsylvania
  • 8:00 AM - 9:00 AM ET
    3520 - The Safety and Efficacy of Cadonilimab in the First-Line Treatment of Recurrent or Metastatic Cervical Cancer: A Retrospective, Real-World Study
    Location: Hall C
    Presenter: Ge Jin, PhD – The Fourth Hospital of Hebei Medical University
  • 8:00 AM - 9:00 AM ET
    3521 - Implementation of a Radiation Oncology Protocol Committee for Clinical Trial Review and Prioritization
    Location: Hall C
    Presenter: Melinda Jin – Penn State University
  • 8:00 AM - 9:00 AM ET
    3522 - Implementation and Evaluation of a Patient-Reported Health Status Survey for Survivors of Childhood Malignancies Treated with Radiation
    Location: Hall C
    Presenter: Jaitri Joshi, MS – Massachusetts General Hospital
  • 8:00 AM - 9:00 AM ET
    3523 - Eight-Year Results of a Phase II Prospective Trial of Proton Therapy for Non-Metastatic Pediatric Non-Rhabdomyosarcoma Soft Tissue and Bone Sarcomas
    Location: Hall C
    Presenter: Soo Kang, BSN – Massachusetts General Hospital
  • 8:00 AM - 9:00 AM ET
    3524 - Human Papilloma Virus Profiles in Healthy Women, Women with Cervical Intraepithelial Neoplasia, and Women with Invasive Cervical Cancer in Botswana
    Location: Hall C
    Presenter: Caroline Kernell, BS – UT Southwestern Medical Center
  • 8:00 AM - 9:00 AM ET
    3525 - Hypofractionated Radiotherapy in Treatment of Cervical Cancer: A Systematic Review
    Location: Hall C
    Presenter: Madelyn Fahhoum, BA – Medical College of Wisconsin
  • 8:00 AM - 9:00 AM ET
    3526 - Dosimetric Evaluation of a Novel HDR Brachytherapy Applicator for Intensity-Modulated Intracavitary Brachytherapy in Locally Advanced Cervical Cancers
    Location: Hall C
    Presenter: Dohyeon Kim, PhD, Resident – National Cancer Center, Korea
  • 8:00 AM - 9:00 AM ET
    3527 - Outcomes Following Radiation Therapy (RT) for Embryonal Tumor with Multilayered Rosettes (ETMR): Results from the Pediatric Proton/Photon Consortium Registry (PPCR)
    Location: Hall C
    Presenter: Jacquelyn Krisch, MD, ME – SUNY Upstate Medical University
  • 8:00 AM - 9:00 AM ET
    3528 - Utility of Virtual Information Sessions to Inform Medical Students about Radiation Oncology Residency Programs
    Location: Hall C
    Presenter: Conley Kriegler, MD – University of Alberta
  • 8:00 AM - 9:00 AM ET
    3529 - Impact of Didactic Instruction upon Medicolegal Quality of Radiation Oncology Resident Physician Documentation
    Location: Hall C
    Presenter: Vaishvi Patel, MD – Cross Cancer Institute
  • 8:00 AM - 9:00 AM ET
    3530 - Hybrid Intracavitary-Interstitial High-Dose-Rate Brachytherapy for Vaginal Recurrence from Endometrial Cancer
    Location: Hall C
    Presenter: Pavnesh Kumar, MD, MBBS – The Ohio State University James Cancer Hospital
  • 8:00 AM - 9:00 AM ET
    3531 - Assessment of Speaker Roles for Radiation Oncologists in ASCO Annual Conference Education Sessions
    Location: Hall C
    Presenter: Ritesh Kumar, MD – Rutgers Cancer Institute of New Jersey
  • 8:00 AM - 9:00 AM ET
    3532 - A Pilot Study of an Educational and Clinical Mobile Application for Patients Receiving Radiation Treatment
    Location: Hall C
    Presenter: Colton Ladbury, MD, BS – City of Hope National Medical Center
  • 8:00 AM - 9:00 AM ET
    3533 - Outcomes of Exclusive Use of Magnetic Resonance Image-Guided Brachytherapy in Locally Advanced Cervical Cancer with a Focus on Central Control and Evaluation of an Auto-Segmentation Tool for High-Risk
    Location: Hall C
    Presenter: Yosef Landman Gigi, MD – Johns Hopkins Hospital
  • 8:00 AM - 9:00 AM ET
    3534 - Analysis of Radiation Oncology Residency Program Websites: A Call for Further Improvements
    Location: Hall C
    Presenter: David Lee, MD – University of Miami - Sylvester Cancer Center
  • 8:00 AM - 9:00 AM ET
    3535 - Prognostic Value of Metabolic Change in Patients with Locally Advanced Cervical Cancer Treated with Chemoradiotherapy
    Location: Hall C
    Presenter: Haoting Shi, MD – Ruijin Hospital, Shanghai Jiaotong University School of Medicine
  • 8:00 AM - 9:00 AM ET
    3536 - AI-Assisted 3D Printing Transvaginal Template Guidance for Interstitial Brachytherapy in Patients with Cervical Cancer with Parametrial Invasion
    Location: Hall C
    Presenter: Huiling Li, MD – Affiliated Hospital of Xuzhou Medical University
  • 8:00 AM - 9:00 AM ET
    3537 - Characterization of Clinical Outcomes for Patients with Relapsed High-Risk Neuroblastoma after External Beam Radiotherapy
    Location: Hall C
    Presenter: Kevin Liu, MD, DPhil – Brigham and Womens Hopsital
  • 8:00 AM - 9:00 AM ET
    3538 - Animated, Multilingual, ADA-Accessible Videos to Improve Patient Education and Radiation Treatment Outcomes
    Location: Hall C
    Presenter: Eulanca Liu, MD, PhD – UCLA Radiation Oncology
  • 8:00 AM - 9:00 AM ET
    3539 - Implementation of a Holistic Review Pipeline for Radiation Oncology Residency Applicants: A Test Case Evaluating Gender Equity
    Location: Hall C
    Presenter: Eulanca Liu, MD, PhD – UCLA Radiation Oncology
  • 8:00 AM - 9:00 AM ET
    3540 - Impact of Total Dose and Treatment Modality on Survival in Inoperable Endometrial Cancer in the National Cancer Database
    Location: Hall C
    Presenter: Alexander Lukez, MD – Fox Chase Cancer Center
  • 8:00 AM - 9:00 AM ET
    3541 - Adaptive Magnetic Resonance Guided Radiation Therapy for Definitive Treatment of Gynecologic Malignancies
    Location: Hall C
    Presenter: Kathryn Marqueen, MD – University of Texas MD Anderson Cancer Center
  • 8:00 AM - 9:00 AM ET
    3542 - Impact of Role Identification Badge Placards on Radiation Oncology Staff Job Satisfaction and Wellbeing
    Location: Hall C
    Presenter: Elizabeth McKone, MD – Mayo Clinic Rochester
  • 8:00 AM - 9:00 AM ET
    3543 - Utility of 68Ga DOTA-Octreotate PET/CT in Characterization of Pediatric Neuroendocrine Tumors
    Location: Hall C
    Presenter: Elizabeth McKone, MD – Mayo Clinic Rochester
  • 8:00 AM - 9:00 AM ET
    3544 - Gaps in Understanding of Cardio-Oncology amongst Cardiologists and Oncologists Working in Multidisciplinary Academic Institutions
    Location: Hall C
    Presenter: Shagun Misra, MD – Sanjay Gandhi Postgraduate Institute of Medical Sciences
  • 8:00 AM - 9:00 AM ET
    3545 - Twice Daily Template-Based Interstitial Brachytherapy for Gynecologic Cancers: What is the Optimal Dose?
    Location: Hall C
    Presenter: Ria Mulherkar, MD – UPMC Cancer Center
  • 8:00 AM - 9:00 AM ET
    3546 - Preclinical efficacy of TTFields and PARP inhibitors in ovarian cancer models
    Location: Hall C
    Presenter: Helena Mumblat, PhD – Novocure
  • 8:00 AM - 9:00 AM ET
    3547 - Tumor Treating Fields (TTFields) Augment the Efficacy of Cisplatin for Treatment of Cervical Cancer, In Vitro and In Vivo
    Location: Hall C
    Presenter: Helena Mumblat, PhD – Novocure
  • 8:00 AM - 9:00 AM ET
    3548 - The Global Framework for the Education of Radiation Therapists.
    Location: Hall C
    Presenter: Colleen Dickie, MS, RT – Princess Margaret Cancer Centre
  • 8:00 AM - 9:00 AM ET
    3549 - High-Dose-Rate Interstitial Brachytherapy for Cervical Cancer - The More Catheters the Merrier?
    Location: Hall C
  • 8:00 AM - 9:00 AM ET
    3550 - Impact of Cachexia on Overall Survival and Recurrence Rates in Locally Advanced Cervical Cancer Patients
    Location: Hall C
    Presenter: Linzi Paul, MS – LSUHSC- New Orleans
  • 8:00 AM - 9:00 AM ET
    3551 - Adjuvant Treatment and Outcomes for Stage III Serous Endometrial Cancer Patients at a Single Institution
    Location: Hall C
    Presenter: Joanne Jang, MD, PhD – Beth Israel Deaconess Medical Center
  • 8:00 AM - 9:00 AM ET
    3552 - Outcomes of Salvage Radiotherapy and Chemotherapy for Vaginal Vault Carcinoma Following Earlier Hysterectomy
    Location: Hall C
    Presenter: Satyajit Pradhan, MD – Mahamana Pandit Madan Mohan Malaviya Cancer Centre
  • 8:00 AM - 9:00 AM ET
    3553 - Pre-Radiotherapy Absolute Lymphocyte Counts Predict Benefit from Having Cisplatin Chemotherapy with Radiotherapy in Cervical Carcinoma
    Location: Hall C
    Presenter: James Price, MBBS, FRCR – The Christie NHS Foundation Trust
  • 8:00 AM - 9:00 AM ET
    3554 - A Simple Method to Generate Descriptive Images for Recurrent Cervix Cancer Using Predictive ResNet Model Weights and Feature Maps
    Location: Hall C
    Presenter: Destie Provenzano, MS – George Washington University
  • 8:00 AM - 9:00 AM ET
    3555 - Misinformation Regarding Medical Cannabis as a Cancer Cure among Patients with Central Nervous System and Gastrointestinal Cancer
    Location: Hall C
    Presenter: Vera Qu, BS – University of Southern California Keck School of Medicine
  • 8:00 AM - 9:00 AM ET
    3556 - Impact of Resident-Lead Didactics on Referring Trainee Radiotherapy Knowledge and Consultation Comfort
    Location: Hall C
    Presenter: Katelyn Ragland, MD – University of Alabama at Birmingham
  • 8:00 AM - 9:00 AM ET
    3557 - Studying the Necessity to Account for Rotational Errors in a 3D PTV for Translational Motion in Pelvic Radiotherapy
    Location: Hall C
    Presenter: Vrushab Rao, MBBS, PDCR – Ruby Hall Clinic
  • 8:00 AM - 9:00 AM ET
    3558 - Improving Academic Productivity or Raising Ethical Concerns? Time-Series Analysis of AI-Assisted Scientific Writing
    Location: Hall C
    Presenter: Charlotte Read, MS, BS – Icahn School of Medicine at Mount Sinai
  • 8:00 AM - 9:00 AM ET
    3559 - CT and MRI Time Difference on OAR Dose in HDR for Cervical Cancer
    Location: Hall C
    Presenter: Atefeh Rezaei, MD – Case Comprehensive Cancer Center, Case Western Reserve University
  • 8:00 AM - 9:00 AM ET
    3560 - Neighborhood Socioeconomic Status of Women with Locally Advanced Cervical Cancer and Access to Brachytherapy
    Location: Hall C
    Presenter: Lucy Rose, MA – Ohio State University College of Medicine
  • 8:00 AM - 9:00 AM ET
    3561 - Systematic Review and Meta-Analysis of Adjuvant Radiation Dose for Pediatric Patients (=22y) with Non-Metastatic Intracranial Ependymomas
    Location: Hall C
    Presenter: Melanie Rose, MD – Dartmouth-Hitchcock Medical Center
  • 8:00 AM - 9:00 AM ET
    3562 - Comparative Analysis of Adjuvant Treatment Outcomes in Stage III Endometrial Cancer
    Location: Hall C
    Presenter: Joanne Jang, MD, PhD – Beth Israel Deaconess Medical Center
  • 8:00 AM - 9:00 AM ET
    3563 - Impact of Adjuvant Radiation on Mortality in Surgically Staged Stage IB Grade 3 and II Endometrioid Endometrial Cancer: Propensity Score Matching Analysis
    Location: Hall C
    Presenter: Shoshana Rosenzweig, MD – Memorial Sloan Kettering Cancer Center
  • 8:00 AM - 9:00 AM ET
    3564 - Assessment of a Student-Run Multidisciplinary Oncology Shadowing Program
    Location: Hall C
    Presenter: Marco Santos Teles, BS – Rutgers New Jersey Medical School
  • 8:00 AM - 9:00 AM ET
    3565 - Implementation of a Multidisciplinary Cancer Center Clinical Oncology and Research Symposium for Medical Students, Residents, Fellows and Faculty
    Location: Hall C
    Presenter: Aronne Schottstaedt, MD, MS – MCWAH
  • 8:00 AM - 9:00 AM ET
    3566 - Application of NRS Nutritional Status Evaluation in Radiotherapy and Chemotherapy of Patients with Cervical Cancer
    Location: Hall C
    Presenter: Lang Shan
  • 8:00 AM - 9:00 AM ET
    3567 - Ovary Sparing IMRT for Locally Advanced Cervical Cancer after Laparoscopic Ovarian Transposition
    Location: Hall C
    Presenter: Jeffrey Shogan, DO – University of Pittsburgh Medical Center
  • 8:00 AM - 9:00 AM ET
    3568 - Efficacy and Safety of Brachytherapy in Primary Vaginal Carcinoma
    Location: Hall C
    Presenter: Ingrid Sidibe, MD – CHU de Quebec - Universite Laval - Centre integre de cancerologie
  • 8:00 AM - 9:00 AM ET
    3569 - Pre-Treatment and Pre-Brachytherapy MRI First-Order Radiomic Features By a Commercial Software As Survival Predictors in Radiotherapy for Cervical Cancer
    Location: Hall C
    Presenter: Tissana Prasartseree, MD – Siriraj Hospital Mahidol University
  • 8:00 AM - 9:00 AM ET
    3570 - Utilization Assessment of the Introductory Radiation Oncology Curriculum (IROC) for Radiation Oncology Trainees
    Location: Hall C
    Presenter: Amanda Stark, MD – VCU Health Stony Point/Massey Cancer Center
  • 8:00 AM - 9:00 AM ET
    3571 - Interstitial High-Dose Rate Brachytherapy with or without Interstitial Hyperthermia for Gynecologic Malignancies
    Location: Hall C
    Presenter: Austin Thompson, MD – University of Maryland Medical Center
  • 8:00 AM - 9:00 AM ET
    3572 - The MEDaphor Project: Comparing Readability and Access of Novel Cancer Education Materials for Patients with Limited Health Literacy
    Location: Hall C
    Presenter: Michelle Tibbs, MD, MAS – UCSD Radiation Medicine and Applied Sciences
  • 8:00 AM - 9:00 AM ET
    3573 - The Effect of Institutional Support vs. Peer Influence on Match Rates into Radiation Oncology over 5 Years: 2019 to 2023
    Location: Hall C
    Presenter: Olivia Trumble, BS – University of Florida College of Medicine
  • 8:00 AM - 9:00 AM ET
    3574 - Evaluation of a Graphic Narrative Patient Education Tool to Reduce Pre-Treatment Anxiety for Patients Receiving Radiotherapy in a Latin American Hospital
    Location: Hall C
    Presenter: Augustin Vannier, BA – University of Chicago Pritzker School of Medicine
  • 8:00 AM - 9:00 AM ET
    3575 - A Randomized Crossover Trial to Compare Two Rectum Separation Techniques during High-Dose-Rate Intracavitary Brachytherapy with Tandem-Ring Applicators for Cancer Cervix
    Location: Hall C
    Presenter: Siddharth Vats, MD – Cancer Hospital Shimla
  • 8:00 AM - 9:00 AM ET
    3576 - Dosimetric Effects of Intrafraction Changes in High Dose Rate (HDR) Cervical Brachytherapy - Can We Avoid Replanning for Every Fraction in MR Guided Brachytherapy Era?
    Location: Hall C
    Presenter: Jeyaanth Venkatasai, MD, MBBS, FRCR – Guy's and St Thomas' NHS Foundation Trust
  • 8:00 AM - 9:00 AM ET
    3577 - A Single-Institution Retrospective Analysis of the TBI-ARC Technique in Patients Who Received Total Body Irradiation
    Location: Hall C
    Presenter: Benson Wan, MD, BS – McGill University
  • 8:00 AM - 9:00 AM ET
    3578 - Comparing the Effects of Paclitaxel Liposomes and Albumin-Bound Paclitaxel on the Tumor Regression Rate among Cervical Cancer Patients Undergoing Concurrent Radiotherapy
    Location: Hall C
    Presenter: Che Wang – The First Affiliated Hospital of Xi'an Jiaotong University
  • 8:00 AM - 9:00 AM ET
    3579 - Investigation and Analysis of Nutritional Risks on Oral Nutrition Supplementation during the Peri-Radiotherapy Period: A Multicenter Cross-Sectional Study
    Location: Hall C
    Presenter: Cong Wang, PhD – Qilu Hospital of Shandong University
  • 8:00 AM - 9:00 AM ET
    3580 - The Association of Linear Energy Transfer and Dose with Radiation Necrosis after Proton Therapy in Pediatric Posterior Fossa Tumors
    Location: Hall C
    Presenter: Jarey Wang, MD, PhD – Johns Hopkins University School of Medicine
  • 8:00 AM - 9:00 AM ET
    3581 - Comprehensive Evaluation of the Prognostic Value of Hematological Parameters, Nutritional Status Indices and Serum Tumor Markers in Patients with Locally Advanced Cervical Cancer: A Retrospective Stud
    Location: Hall C
    Presenter: Shanshan Wang, PhD, MS, BS, MBBS – Shanghai Jiao Tong University
  • 8:00 AM - 9:00 AM ET
    3582 - Compared to 18F-FDG PET/CT, the Value of 18F-NOTA TATE PET/CT in Predicting the Short-Term Outcome of Neuroblastoma in Children
    Location: Hall C
  • 8:00 AM - 9:00 AM ET
    3583 - Prognosis of Children with Rhabdomyosarcoma Treated with Radiotherapy
    Location: Hall C
  • 8:00 AM - 9:00 AM ET
    3584 - Appraisal of Utility of ctDNA in Patients with Vulvar Cancer Treated with Radiation: Early Report
    Location: Hall C
    Presenter: Gabriella Wernicke, MD, MS – Northwell Health Cancer Institute
  • 8:00 AM - 9:00 AM ET
    3585 - Analyzing Stage Migration between the FIGO 2009 and 2023 Staging Classifications in Endometrial Cancer Patients
    Location: Hall C
    Presenter: John White, MD – University of Chicago
  • 8:00 AM - 9:00 AM ET
    3586 - Defining a Radiation Oncology Observership Curriculum via the Delphi Method
    Location: Hall C
    Presenter: Matthew Abrams, MD – Beth Israel Deaconess Medical Center
  • 8:00 AM - 9:00 AM ET
    3587 - Implementing a Flipped Classroom Concept for Radiation Oncology Physics Curriculum
    Location: Hall C
    Presenter: Christopher Williamson, MD, MS – Emory University
  • 8:00 AM - 9:00 AM ET
    3588 - Overall Experience of Two Clinical Trials for FUS-Mediated Blood Brain Barrier-Opening for Patients with DIPG/DMG Delivered in Radiation Oncology
    Location: Hall C
    Presenter: Cheng-Chia Wu, MD, PhD – Virginia Tech Carilion School of Medicine
  • 8:00 AM - 9:00 AM ET
    3589 - Effects of Vertebral-Body-Sparing Proton Craniospinal Irradiation on Spinal Growth and Acute Toxicities in Pediatric Patients Using Pencil Beam Scanning
    Location: Hall C
    Presenter: Chuyu Xia, MD – Peking University First Hospital
  • 8:00 AM - 9:00 AM ET
    3590 - Position Selection for Postoperative Cervical Cancer Treatment with Volumetric Modulated Arc Therapy: Supine or Prone Position
    Location: Hall C
    Presenter: Nan Xiao, MD – Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
  • 8:00 AM - 9:00 AM ET
    3591 - Phase II Study of Induction Immunotherapy Combined with Platinum-Base Doublet Chemotherapy Followed by Immunotherapy and Chemoradiotherapy in High-Risk Locally Advanced Cervical Cancer
    Location: Hall C
    Presenter: Xiao-Fan Li, MD
  • 8:00 AM - 9:00 AM ET
    3592 - Problem-Based Learning on the WeChat Public Platform in Radiation Oncology Residency Training Programs
    Location: Hall C
    Presenter: Yi Rui Zhai, MD – National Cancer Center/National Clinical Research Center for Cance
  • 8:00 AM - 9:00 AM ET
    3593 - Analysis of Conditional Survival in Patients with Gynecologic Malignancies Treated with Radiation
    Location: Hall C
    Presenter: Jimmy Patel, MD, PhD – Emory University
  • 8:00 AM - 9:00 AM ET
    3594 - A CNN-Based Dose Prediction Method for Brachytherapy Treatment Planning of Patients with Cervical Cancer
    Location: Hall C
    Presenter: Wenjun Zhang
  • 8:00 AM - 9:00 AM ET
    3595 - Evaluating the Potential of Proton Therapy for Whole Abdominal Radiotherapy
    Location: Hall C
    Presenter: Conan Zhao, PhD – Mayo Clinic Alix School of Medicine
  • 8:00 AM - 9:00 AM ET
    3596 - Incorporating POLD1 for Prognostication of Black Endometrial Cancer Patients
    Location: Hall C
    Presenter: Shuhua Zheng, DO, PhD – Northwestern Feinberg School of Medicine
  • 10:45 AM - 12:00 PM ET
    2477 - Repeat Stereotactic Radiosurgery in Patients with Spinal Metastases Recurrent Following Initial Radiosurgery
    Location: Hall C
    Presenter: Joseph Abi Jaoude, MD – Stanford University
  • 10:45 AM - 12:00 PM ET
    2478 - PD-L1, Tumor Mutational Burden (TMB) and Intracranial Outcomes in Patients with Non-Small Cell Lung Cancer (NSCLC) and Brain Metastases
    Location: Hall C
    Presenter: Elio Adib, MD – Mass General Brigham
  • 10:45 AM - 12:00 PM ET
    2479 - Ablative Stereotactic MR-Guided Adaptive Radiotherapy in Patients with Infra-Diaphragmatic Oligometastatic Disease
    Location: Hall C
    Presenter: Eyub Yasar Akdemir, MD – Baptist Health
  • 10:45 AM - 12:00 PM ET
    2480 - Radiation Therapy for Palliation of Symptomatic Bone Metastases: An ASTRO Clinical Practice Guideline
    Location: Hall C
    Presenter: Sara Alcorn, MD, PhD, MPH – University of Minnesota
  • 10:45 AM - 12:00 PM ET
    2481 - Metastasis-Directed Stereotactic Body Radiation Therapy in Oligometastatic and Oligoprogressive Solid Malignancy: Outcomes and Effect on Systemic Treatment
    Location: Hall C
    Presenter: Abdulla Alzibdeh, MD – King Hussein Cancer Center
  • 10:45 AM - 12:00 PM ET
    2482 - Patient Reported Outcomes Following Brain Reirradiation (reRT) with Proton Therapy
    Location: Hall C
    Presenter: Joshua Anderson, MD, BS – Emory University School of Medicine
  • 10:45 AM - 12:00 PM ET
    2483 - Response to ONC201 by Prior Radiotherapy Regimen in Recurrent H3 K27M-Mutant Diffuse Midline Glioma
    Location: Hall C
    Presenter: Pablo Lee, MD – Chimerix
  • 10:45 AM - 12:00 PM ET
    2484 - Incidence and Risk Factors Associated with Need for Treatment of Vertebral Compression Fractures after Spine Stereotactic Radiosurgery
    Location: Hall C
    Presenter: Jessica Bai, BS – Case Western Reserve School of Medicine
  • 10:45 AM - 12:00 PM ET
    2485 - Additional Salvage Spine Stereotactic Radiosurgery (SRS) Following Radiographic Progression of Spinal Metastases in Patients Previously Re-Irradiated with SRS
    Location: Hall C
    Presenter: Jessica Bai, BS – Case Western Reserve School of Medicine
  • 10:45 AM - 12:00 PM ET
    2486 - Progesterone Contraception and Tumor-Related Visual Impairment in Premenopausal Women with Meningioma Referred for Radiation
    Location: Hall C
    Presenter: Morgan Bailey, MD – University of Cincinnati - Barrett Cancer Center
  • 10:45 AM - 12:00 PM ET
    2487 - Efficacy of Stereotactic Body Radiation Therapy (SBRT) to Prolong Systemic Therapy (ST) for Patients with Oligoprogressive (OP) Metastatic Breast Cancer (MBC)
    Location: Hall C
    Presenter: Jose Bazan, MD, MS – City of Hope Comprehensive Cancer Center
  • 10:45 AM - 12:00 PM ET
    2488 - Impact of CT-Derived Radiomics and Dosiomics on Survival Prognosis in Glioblastoma Patients
    Location: Hall C
    Presenter: Ali Kamen, PhD – Siemens Healthineers
  • 10:45 AM - 12:00 PM ET
    2489 - Comparison of Distant Intracranial Disease Control between Central Nervous System-Penetrating Tyrosine Kinase Inhibitors and Immunotherapy in Non-Small Cell Lung Cancer Metastatic to Brain Following S
    Location: Hall C
    Presenter: Adam Beighley, MD – Kaiser Permanente Los Angeles Medical Center
  • 10:45 AM - 12:00 PM ET
    2490 - Predictors of Local Failure in the Durable Palliation of Recurrent Breast Cancer Following Concurrent Hyperthermia and High Dose Radiation
    Location: Hall C
    Presenter: Mark Solter, BA – Cleveland Clinic Lerner College of Medicine
  • 10:45 AM - 12:00 PM ET
    2491 - Predictors of Vertebral Compression Fracture Following Spine Stereotactic Body Radiotherapy Vary with Pre-Existing Fracture
    Location: Hall C
    Presenter: Laura Burgess, MD, MS – Odette Cancer Centre
  • 10:45 AM - 12:00 PM ET
    2492 - Predictors of Vertebral Compression Fracture Following Spine Stereotactic Body Radiotherapy Vary with Cause: Iatrogenic or in Conjunction with Local Failure
    Location: Hall C
    Presenter: Laura Burgess, MD, MS – Odette Cancer Centre
  • 10:45 AM - 12:00 PM ET
    2493 - Efficacy and Safety of Magnetic Resonance-Guided Online Adaptive Stereotactic Radiotherapy in Oligometastatic Gynecologic Malignancies: A Multi-Institutional Outcomes Study
    Location: Hall C
    Presenter: Danielle Cerbon, MD – University of Miami
  • 10:45 AM - 12:00 PM ET
    2494 - Clinical Outcomes and Toxicities Associated with Radiation Therapy for Patients with Leptomeningeal Dissemination of Primary Gliomas
    Location: Hall C
    Presenter: Ashley Chavana, BS – Baylor College of Medicine
  • 10:45 AM - 12:00 PM ET
    2495 - Symptom Palliation with QUADSHOT Regimen for Advanced Cervical Cancer
    Location: Hall C
    Presenter: Tsion Chema, MD – Addis Ababa University
  • 10:45 AM - 12:00 PM ET
    2496 - Comparison of Efficacy between Osteolytic vs. Osteoblastic Metastatic Lesion in Lung Cancer Following Radiotherapy
    Location: Hall C
    Presenter: Dong-Jie Chen, MS – ShenZhen Cancer Hospital
  • 10:45 AM - 12:00 PM ET
    2497 - Management of Multiple Brain Metastases with Serial Stereotactic Radiosurgery vs. Whole Brain Radiation Therapy
    Location: Hall C
    Presenter: Jie Jane Chen, MD – University of California, San Francisco
  • 10:45 AM - 12:00 PM ET
    2498 - Impact of KEAP1/NFE2L2 Mutations on Local Recurrence in Patients Receiving Stereotactic Radiosurgery for Non-Small Cell Lung Cancer Brain Metastases
    Location: Hall C
    Presenter: Mark Chen, MD, PhD – Duke University
  • 10:45 AM - 12:00 PM ET
    2499 - Efficacy and Safety of STUPP Regimen ± Anlotinib for Newly Diagnosed Glioblastoma: A Multicenter, Double-Blind, Randomized Phase II Trial
    Location: Hall C
    Presenter: Yuanyuan Chen, MD – Sun Yat-Sen University Cancer Center
  • 10:45 AM - 12:00 PM ET
    2500 - Identifying Risk Factors Associated with Outcomes for Patients with Recurrent and Progressive Meningiomas: A Secondary Analysis of SWOG S9005
    Location: Hall C
    Presenter: Hua-Ren Cherng, MD – University of Maryland Medical Center
  • 10:45 AM - 12:00 PM ET
    2501 - Tumor Treating Fields Utilization for Glioblastoma at a Large Multicenter Academic Practice
    Location: Hall C
    Presenter: David Crompton, MD, BS – Mayo Clinic College of Medicine and Science Jacksonville
  • 10:45 AM - 12:00 PM ET
    2502 - Modern Patterns of Failure for Glioblastoma at a Large Multicenter Academic Practice
    Location: Hall C
    Presenter: David Crompton, MD, BS – Mayo Clinic College of Medicine and Science Jacksonville
  • 10:45 AM - 12:00 PM ET
    2503 - Identification of Triapine as a Novel Radiosensitizer in Glioblastoma
    Location: Hall C
    Presenter: Tiantian Cui, MD, PhD – City of Hope National Medical Center
  • 10:45 AM - 12:00 PM ET
    2504 - Optimal Intervention Timing for Craniocerebral Radiotherapy in Patients with EGFR-Mutant Lung Adenocarcinoma and Brain Metastases
    Location: Hall C
    Presenter: Guangchuan Deng, PhD, MBBS – Shandong Cancer Hospital and Institute
  • 10:45 AM - 12:00 PM ET
    2505 - Inter-Fraction Dynamics and Dosimetric Assessment during MR-Guided Online Adaptive Radiotherapy for Glioblastoma
    Location: Hall C
    Presenter: Shouliang Ding, PhD, MS – Sun Yat-Sen University Cancer Center
  • 10:45 AM - 12:00 PM ET
    2506 - Exploring the Impact of Personalized Ultra-Fractionated Stereotactic Adaptive Radiotherapy for the Treatment of Brain Metastases
    Location: Hall C
    Presenter: Michael Dohopolski, MD – UT Southwestern Medical Center
  • 10:45 AM - 12:00 PM ET
    2507 - Characterization of Clinical Feasibility, Reproducibility and Dosimetric Impact of Palliative Immobilization Devices to Optimize Patient Comfort
    Location: Hall C
    Presenter: Victoria Doss, MD – Johns Hopkins Medicine
  • 10:45 AM - 12:00 PM ET
    2508 - Time-Delayed Contrast-Enhanced T2-FLAIR and Accuracy of GTV Determination in Brain Metastases
    Location: Hall C
    Presenter: Shanshan Du, MS
  • 10:45 AM - 12:00 PM ET
    2509 - In-Depth Pattern-of-Failure Analysis of Grade 2 Meningiomas after Proton and Photon-Based Fractionated Radiotherapy
    Location: Hall C
    Presenter: Felix Ehret, MD – Massachusetts General Hospital
  • 10:45 AM - 12:00 PM ET
    2510 - Dosimetric Analysis of Salvage SBRT Reirradiation after Initial Spine SBRT; Single Institution Experience
    Location: Hall C
    Presenter: Ahmed Elguindy, MD – James Cancer Hospital-Solove Research Institute
  • 10:45 AM - 12:00 PM ET
    2511 - Cumulative Incidence of Sarcoma Brain Metastases: Report from a High-Volume Cancer Center
    Location: Hall C
    Presenter: Ayah Erjan, MD
  • 10:45 AM - 12:00 PM ET
    2512 - Clinical Experience with Palliative Treatment of Bulky Tumors Using VMAT-Based Lattice Radiotherapy
    Location: Hall C
    Presenter: Diego Fernandez, MD, PhD – Centro Medico Dean Funes
  • 10:45 AM - 12:00 PM ET
    2513 - Adaptive Radiation Therapy (ART) of Spinal Metastases: Motion between a Rock and a Hard Place
    Location: Hall C
    Presenter: Robert Freeman, MD – Fox Chase Cancer Center
  • 10:45 AM - 12:00 PM ET
    2514 - Long-Term Impact of a High-Volume Inpatient Radiation Oncology Consult Service on Cancer Care Delivery
    Location: Hall C
    Presenter: Morgan Freret, MD, PhD – Memorial Sloan Kettering Cancer Center
  • 10:45 AM - 12:00 PM ET
    2515 - Contrast-Enhancing Lesions Induced by CNS-Directed Intensity Modulated Proton Therapy: Distribution Patterns, Kinetics and Clinical Outcomes
    Location: Hall C
    Presenter: Omer Gal, MD – Miami Cancer Institute: Baptist Health South Florida
  • 10:45 AM - 12:00 PM ET
    2516 - Assessing the Outcomes of Personalized Ultra-Fractionated Stereotactic Adaptive Radiotherapy in Reirradiation for Recurrent Glioblastoma
    Location: Hall C
    Presenter: Luiza Giuliani Schmitt, MD – University of Texas Southwestern Medical Center
  • 10:45 AM - 12:00 PM ET
    2517 - Genomic Signature for Initial Brain Metastasis Velocity (iBMV) in Non-Small Cell Lung Cancer Patients: The Elusive Biomarker to Predict the Development of Brain Metastases?
    Location: Hall C
    Presenter: Sarah Glynn, DO – Wake Forest Baptist Health
  • 10:45 AM - 12:00 PM ET
    2518 - Temporally Corrected Dose Accumulation: Standardizing Analysis and Documentation of Re-Irradiation
    Location: Hall C
    Presenter: Vishhvaan Gopalakrishnan, MD, MSE – Johns Hopkins Medicine
  • 10:45 AM - 12:00 PM ET
    2519 - Mapping Symptomatic Radionecrosis after Stereotactic Radiosurgery with Functional Magnetic Resonance Imaging
    Location: Hall C
    Presenter: Chengcheng Gui, MD – Memorial Sloan Kettering Cancer Center
  • 10:45 AM - 12:00 PM ET
    2520 - Stereotactic Radiosurgery and Whole Brain Radiotherapy for Germ Cell Tumor Brain Metastases: Practice Patterns and Outcomes
    Location: Hall C
    Presenter: Chengcheng Gui, MD – Memorial Sloan Kettering Cancer Center
  • 10:45 AM - 12:00 PM ET
    2521 - Clinicogenomic Predictors of Survival and Intracranial Progression after Stereotactic Radiosurgery for Colorectal Cancer Brain Metastases
    Location: Hall C
    Presenter: Chengcheng Gui, MD – Memorial Sloan Kettering Cancer Center
  • 10:45 AM - 12:00 PM ET
    2522 - Stereotactic Body Radiation Therapy vs. Palliative Radiotherapy, with or without Immunotherapy, in Metastatic Bladder Cancer: A Canadian Population Analysis
    Location: Hall C
    Presenter: Enrique Gutierrez, MD – Princess Margaret Cancer Center
  • 10:45 AM - 12:00 PM ET
    2523 - Perspectives on Oligometastatic Disease Treatment: A Survey Among Radiation Oncologists and Medical Oncologists
    Location: Hall C
    Presenter: Ruchika Gutt, MD – Washington DC VA Medical Center
  • 10:45 AM - 12:00 PM ET
    2524 - The Impact of Sequencing Checkpoint Inhibitors and Radiotherapy on Clinical Outcomes of Patients with Melanoma Brain Metastases: Meta-Analysis of Comparative Studies
    Location: Hall C
    Presenter: Philip Haddad, MD, MPH, MHA – LSU Health Sciences Center Shreveport
  • 10:45 AM - 12:00 PM ET
    2525 - Memory Tract Sparing Using Diffuse Tensor Imaging in Radiation Planning of Primary Brain Tumor
    Location: Hall C
    Presenter: Ory Haisraely, MD, MPH – MD Anderson Cancer Center
  • 10:45 AM - 12:00 PM ET
    2526 - Re-Irradiation of Anaplastic Meningioma. Local Control Factors and Toxicity Report.
    Location: Hall C
    Presenter: Ory Haisraely, MD, MPH – MD Anderson Cancer Center
  • 10:45 AM - 12:00 PM ET
    2527 - Impact of Race/Ethnicity on Inpatient vs. Outpatient Access to Palliative RT
    Location: Hall C
    Presenter: Anthony Heng, BS – University of Washington School of Medicine
  • 10:45 AM - 12:00 PM ET
    2528 - Stereotactic Radiosurgery for Newly Diagnosed and Recurrent Chordomas of the Skull Base and Spine
    Location: Hall C
    Presenter: Jamie Ho, BS – Stanford Medicine
  • 10:45 AM - 12:00 PM ET
    2529 - Prognostic Factors for Early Demise Following Palliative Spatially Fractionated Radiotherapy
    Location: Hall C
    Presenter: Jared Hobson, MD, BSN, RN – Mayo Clinic Rochester
  • 10:45 AM - 12:00 PM ET
    2530 - Magnetic Resonance-Guided Stereotactic Body Radiotherapy for Reirradiation in the Abdomen
    Location: Hall C
    Presenter: Thomas Howard, MD, PhD – Mass General Brigham/Massachusetts General Hospital/Harvard Med School
  • 10:45 AM - 12:00 PM ET
    2531 - Effect of Preoperative vs. Postoperative Radiation on Leptomeningeal Disease in Treatment of Brain Metastases
    Location: Hall C
    Presenter: John Hoyle, MD, MS – University of Alabama Birmingham School of Medicine
  • 10:45 AM - 12:00 PM ET
    2532 - Assessing the Impact of Targeted Therapy and Immunotherapy on Clinical Outcomes in Intact Brain Metastases Treated with Stereotactic Radiosurgery - A Single Institution Experience
    Location: Hall C
    Presenter: Ahmad Kh. Ibrahimi, MD – King Hussein Cancer Center
  • 10:45 AM - 12:00 PM ET
    2533 - Effect of Molecular Classification on Glioma Outcomes in Hispanic Patients
    Location: Hall C
    Presenter: Emily Ishak, BS – Columbia University College of Physicians and Surgeons
  • 10:45 AM - 12:00 PM ET
    2534 - Simulation-Free Single-Fraction Stereotactic Body Radiotherapy for Non-Spine Bone Metastases
    Location: Hall C
    Presenter: Joanna Javor, MS, CMD, RT – UHN
  • 10:45 AM - 12:00 PM ET
    2535 - Nine Month Report Assessing the Safety and Effectiveness of Amniotic Bladder Therapy in Patients with Refractory Chronic Radiation Cystitis
    Location: Hall C
    Presenter: Julian Jeberaeel, DO – Detroit Medical Center/Wayne State University
  • 10:45 AM - 12:00 PM ET
    2536 - Outcomes of Palliative Whole Posterior Fossa Radiotherapy for Adult Brain Metastases
    Location: Hall C
    Presenter: Cecilia Jiang, MD – University of Pennsylvania
  • 10:45 AM - 12:00 PM ET
    2537 - External Validation of a Novel Prognostic Score for Patients with Brain Metastases Referred for Stereotactic Radiosurgery
    Location: Hall C
    Presenter: David Johnston, MB, MBBCHIR – NHS
  • 10:45 AM - 12:00 PM ET
    2538 - Modern Photon-Based Craniospinal Irradiation in Leptomeningeal Disease
    Location: Hall C
    Presenter: Emily Keit, MD – Moffitt Cancer Center
  • 10:45 AM - 12:00 PM ET
    2539 - Brain Metastases Treated by Stereotactic Radiotherapy: Real-Time Surveillance of Acute and Delayed Toxicities via Enterprise-Wide Standardized Radiation Oncology OIS Platform
    Location: Hall C
    Presenter: Andrew Kennedy, MD, FACRO – Sarah Cannon Cancer Center at TriStar Health
  • 10:45 AM - 12:00 PM ET
    2540 - A Combined Phase 0/1b Trial of ATM Inhibitor AZD1390 in Combination with Radiation in Patients with Newly-Diagnosed, MGMT-Unmethylated Glioblastoma
    Location: Hall C
    Presenter: William Kennedy, MD – Barrow Neurological Institute
  • 10:45 AM - 12:00 PM ET
    2541 - Evaluation of 18F-DOPA PET Imaging Features and Impact on Radiation Target Volumes for Patients with Oligodendroglioma
    Location: Hall C
    Presenter: Adam Kessel, MD – Mayo Clinic Rochester
  • 10:45 AM - 12:00 PM ET
    2542 - Multi-Institutional Report of Trastuzumab-Deruxtecan and Stereotactic Radiosurgery for HER2+ Breast Cancer Brain Metastases
    Location: Hall C
    Presenter: Vaseem Khatri, MD – Moffitt Cancer Center
  • 10:45 AM - 12:00 PM ET
    2543 - Association of Age with IDH-Status and Progression in Diffuse Gliomas
    Location: Hall C
    Presenter: Connor Kinslow, MD – Columbia University Irving Medical Center
  • 10:45 AM - 12:00 PM ET
    2544 - Treatment Patterns and Outcomes for Colorectal Cancer Spine Metastases Treated with SRS
    Location: Hall C
    Presenter: Dasha Klebaner, MD, BS, MPH – Stanford University Cancer Center
  • 10:45 AM - 12:00 PM ET
    2545 - Utilization of Brain-Directed Therapy for Patients with Melanoma Brain Metastases Treated with Ipilimumab and Nivolumab
    Location: Hall C
    Presenter: Troy Kleber, MD, MS – MD Anderson Cancer Center
  • 10:45 AM - 12:00 PM ET
    2546 - Single-Fraction vs. Multi-fraction Stereotactic Ablative Body Radiotherapy [SBRT] for Colorectal Pulmonary Oligometastases
    Location: Hall C
    Presenter: Jenna Kocsis, MD – Cleveland Clinic Taussig Cancer Center
  • 10:45 AM - 12:00 PM ET
    2547 - Impact of Concurrent Antibody-Drug Conjugates and Radiotherapy on Symptomatic Radiation Necrosis in Breast Cancer Patients with Brain Metastases: A Multicenter Retrospective Study
    Location: Hall C
    Presenter: Yutaro Koide, MD, PhD – Aichi Cancer Center Hospital
  • 10:45 AM - 12:00 PM ET
    2548 - Comparing Pain Response to Palliative Radiotherapy in Painful Bone Metastases vs. Painful Non-Bone Lesions: A Secondary Analysis of a Prospective Observational Study
    Location: Hall C
    Presenter: Yutaro Koide, MD, PhD – Aichi Cancer Center Hospital
  • 10:45 AM - 12:00 PM ET
    2549 - Local Failure after Radiosurgery for Spinal Metastases with Epidural Spinal Cord Compression
    Location: Hall C
    Presenter: Tanaya Kollipara, BS – Stanford University
  • 10:45 AM - 12:00 PM ET
    2550 - Safety and Efficacy of Combination PRaG Regimen with Dynamic and Precise Regulation of Thymalfasin Dose Based on T Lymphocyte Count for the Treatment of Chemo-Refractory Metastatic Solid Tumors: An Op
    Location: Hall C
    Presenter: Yuehong Kong
  • 10:45 AM - 12:00 PM ET
    2551 - Impact of Systemic Therapy Selection on Brain Metastasis Outcomes in Lung Cancer Patients Treated with Stereotactic Radiosurgery
    Location: Hall C
    Presenter: Rupesh Kotecha, MD – Miami Cancer Institute
  • 10:45 AM - 12:00 PM ET
    2552 - Conventionally Fractionated Reirradiation of Recurrent High Grade Gliomas: A Look at Dose Escalation and Safety
    Location: Hall C
    Presenter: Michael LeCompte, MD, MS – Johns Hopkins Radiation Oncology Kimmel Cancer Center
  • 10:45 AM - 12:00 PM ET
    2553 - Clinical Outcomes of Patients with Oligometastatic Renal Cell Cancer Treated with Stereotactic Body Radiation Therapy: Results from a Prospective Registry Trial
    Location: Hall C
    Presenter: Katie Lee, MD, PhD – The Mayo Clinic
  • 10:45 AM - 12:00 PM ET
    2554 - Genotypically-Selected Pan Cancer Trial of Camonsertib with Palliative Radiation in the Treatment of Metastatic Tumors Harboring an Ataxia-Telangiectasia Mutated (ATM) Mutation
    Location: Hall C
    Presenter: Nancy Lee, MD, FASTRO – Memorial Sloan Kettering Cancer Center
  • 10:45 AM - 12:00 PM ET
    2555 - Comparative Efficacy and Safety of Stereotactic Body Radiation Therapy Dose-Fractionation Regimens for Spinal Metastases: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
    Location: Hall C
    Presenter: Shing Fung Lee, MBBS – National University Hospital
  • 10:45 AM - 12:00 PM ET
    2556 - Population-Based Local Control and Survival Outcomes of Brain Post-Metastasectomy Adjuvant Radiotherapy vs. Observation
    Location: Hall C
    Presenter: Zhang Hao (Jim) Li, MD – BC Cancer Agency
  • 10:45 AM - 12:00 PM ET
    2557 - Deep Learning-Based Automatic Segmentation of Brain Tumors in Heterogenous Multi-Center Magnetic Resonance Imaging Sets
    Location: Hall C
    Presenter: Wenjun Liao, PhD
  • 10:45 AM - 12:00 PM ET
    2558 - Radiotherapy Triggered AEP/EIF4A1/PGE2 Feedback Loop Facilitates Tumor Survival via Regulating Neuronal Senescence
    Location: Hall C
    Presenter: Yingying Lin, PhD – Ruijin Hospital, Shanghai Jiaotong University School of Medicine
  • 10:45 AM - 12:00 PM ET
    2559 - End of Treatment Monocyte and Lymphocyte Counts Predict for Survival over Three Years in Patients with Glioblastoma Treated with Conventional Radiation
    Location: Hall C
    Presenter: I-Chia Liu, MD – Johns Hopkins Radiation Oncology Kimmel Cancer Center
  • 10:45 AM - 12:00 PM ET
    2560 - Quantitative Study of the Changes in the Hippocampus after Radiotherapy Via Multisequence MR Radiomics
    Location: Hall C
    Presenter: Rui Liu, MBBS
  • 10:45 AM - 12:00 PM ET
    2561 - A Pilot Study of Temporally-Modulated Pulsed Radiation Therapy to Reirradiate Recurrent IDH-Mutant Gliomas after Prior External Beam Radiation Therapy: An Interim Analysis
    Location: Hall C
    Presenter: Weiren Liu, MD, MS – Washington University School of Medicine in St. Louis
  • 10:45 AM - 12:00 PM ET
    2562 - Anatomic Delineation of Celiac Axis for Dosimetric Evaluation of Adaptive MRI Treatment
    Location: Hall C
    Presenter: Yirong Liu, MD, PhD – Northwestern Memorial Hospital
  • 10:45 AM - 12:00 PM ET
    2563 - Assessment of Local Control and Pain Relief of Rib Metastases Treated with SBRT
    Location: Hall C
    Presenter: Mauro Loi, MD – Azienda Ospedaliera Universitaria Careggi
  • 10:45 AM - 12:00 PM ET
    2564 - Utilization of Inpatient Radiation Therapy and Spine Surgery during Hospitalization for Metastatic Spinal Cord Compression
    Location: Hall C
    Presenter: Sifan Lu, BA – Maimonides Medical Center/SUNY Downstate HSU
  • 10:45 AM - 12:00 PM ET
    2565 - MRI Relaxometry for Glioblastoma Response Assessment during Radiation Therapy on a 0.35 T MRI Linear Accelerator
    Location: Hall C
    Presenter: Natalia Lutsik, MD – University of Miami Sylvester Comprehensive Cancer Center
  • 10:45 AM - 12:00 PM ET
    2566 - IKBKE, the c-myc/CSF-1 Signaling Axis, and Mediating Recruitment of M2 Tumor-Associated Macrophages (TAMs) after Radiotherapy in Glioblastoma
    Location: Hall C
    Presenter: Weitao Wen, PhD – Shandong Cancer Hospital Affiliated to Shandong First Medical University
  • 10:45 AM - 12:00 PM ET
    2567 - Stereotactic Radiotherapy Alone for Multiple Brain Metastases after Intracranial Progression in Patients with EGFR-Mutant Lung Adenocarcinoma Receiving EGFR-TKIs: A Multi-Center, Single Arm, Phase II
    Location: Hall C
    Presenter: Yuchao Ma, MD – Cancer Institute & Hospital Chinese Acedemy of Medical Sciences
  • 10:45 AM - 12:00 PM ET
    2568 - CDKN2A/B Alterations are Associated with Worse Prognosis in IDH Mutated 1p/19q Co-Deleted Oligodendrogliomas
    Location: Hall C
    Presenter: Wilson Mai, MD, PhD – Stanford University Cancer Center
  • 10:45 AM - 12:00 PM ET
    2569 - Evaluation of the Safety and Efficacy of Stereotactic Body Radiotherapy for Oligometastasis: Real-World Data from a Developing Country
    Location: Hall C
    Presenter: Gustavo Marta, MD, PhD – Hospital Sirio-Libanes
  • 10:45 AM - 12:00 PM ET
    2570 - Reduced Treatment Volumes for Glioblastoma Result in Lower Rates of Radionecrosis and Lymphopenia: A Pooled Analysis
    Location: Hall C
    Presenter: Susan McGovern, MD, PhD – MD Anderson Cancer Center
  • 10:45 AM - 12:00 PM ET
    2572 - Fractionation Sensitivity in Childhood Medulloblastoma: A Roadmap for Individualized Radiotherapy
    Location: Hall C
    Presenter: Christiane Matuschek, MD – University of Duesseldorf
  • 10:45 AM - 12:00 PM ET
    2573 - Feasibility and Outcomes of Navigated Transcranial Magnetic Stimulation Based Diffusion Tensor Imaging Tractography of Motor Pathways in Patients Undergoing Stereotactic Radiosurgery
    Location: Hall C
    Presenter: Jordan McDonald, MD – MD Anderson Cancer Center
  • 10:45 AM - 12:00 PM ET
    2574 - Impact of Tumor-Associated Macrophage/Microglia Markers on Survival Outcome in Lower Grade Glioma Patients
    Location: Hall C
    Presenter: Wei Meng, PhD, MBA – The Ohio State University
  • 10:45 AM - 12:00 PM ET
    2575 - Patient Outcomes Following Palliative Hypofractionated Fast Neutron Therapy
    Location: Hall C
    Presenter: Ankita Menon – University of Washington
  • 10:45 AM - 12:00 PM ET
    2576 - Video Assisted Learning in Supportive Care and Improving Overall Patient PerceptioN of PALLiative Care and Clinical Trials (VISION-PALL)
    Location: Hall C
    Poster Presenter: C Jillian Tsai, MD, PhD, MS – Princess Margaret Cancer Centre, University Health Network, University of Toronto
    Palliative Care
  • 10:45 AM - 12:00 PM ET
    2577 - Phase 2 Study of Stereotactic Body Radiation Therapy Using Intensity-Modulated Radion Therapy with Dose Escalation by Simultaneous Integrated Boost (SIB-IM-SBRT) for Spinal Metastases
    Location: Hall C
    Presenter: Takamasa Mitsuyoshi, MD, PhD – Kobe City Medical Center General Hospital
  • 10:45 AM - 12:00 PM ET
    2578 - Time-Dependent Interactions between Immune Checkpoint Blockade and Stereotactic Radiosurgery for Brain Metastases
    Location: Hall C
    Presenter: Joseph Sia, MB, ChB, PhD, MBBS, FRANZCR – Peter MacCallum Cancer Centre
  • 10:45 AM - 12:00 PM ET
    2579 - Comparison of 3 vs. 5 Fraction Single Isocenter Radiosurgery for Brain Metastases
    Location: Hall C
    Presenter: Luke Moradi, MD – University of Alabama at Birmingham
  • 10:45 AM - 12:00 PM ET
    2580 - Fractionated Stereotactic Radiotherapy for Large Brain Metastases: Investigating Dosimetric Predictors of Radiation-Induced Brain Necrosis
    Location: Hall C
    Presenter: Taro Murai, MD, PhD – Almana General Hospitals
  • 10:45 AM - 12:00 PM ET
    2581 - Outcomes of Stereotactic Radiotherapy with Dose of 38 Gy or 35 Gy in 3 Fractions for Brain Metastases: A Single-Institution Analysis
    Location: Hall C
    Presenter: Hiroto Murata, MD, PhD – Saitama Cancer Center
  • 10:45 AM - 12:00 PM ET
    2582 - Genotype and Sex Impact Memory Function after Brain Irradiation
    Location: Hall C
    Presenter: Jean Nakamura, MD – University of California, San Francisco
  • 10:45 AM - 12:00 PM ET
    2583 - Rib Fracture Outcomes in Patients Receiving Lung Stereotactic Body Radiotherapy
    Location: Hall C
    Presenter: Otasowie Odiase, MD – Kaiser Permanente Los Angeles Medical Center
  • 10:45 AM - 12:00 PM ET
    2584 - Associations between Cognitive Ability and Changes in Quality of Life among Older Adults with Metastatic Cancer Undergoing Palliative Radiation Therapy
    Location: Hall C
    Presenter: Amare Osei – Icahn School of Medicine at Mount Sinai
  • 10:45 AM - 12:00 PM ET
    2585 - Outcomes and Toxicities of Stereotactic Radiosurgery for Large Brainstem Metastases
    Location: Hall C
    Presenter: Jacob Oyeniyi, MD – Corewell Health William Beaumont University Hospital
  • 10:45 AM - 12:00 PM ET
    2586 - Early Apparent Diffusion Coefficient (ADC) Changes during Concurrent Chemoradiation (CRT): An Imaging Biomarker for Recurrence Prediction in Glioblastoma
    Location: Hall C
    Presenter: Daniel Palhares, MD, MSc – Sunnybrook Odette Cancer Centre
  • 10:45 AM - 12:00 PM ET
    2587 - A Prospective Survey Study of Radiation Therapy Patient Interest in Psychedelic Research
    Location: Hall C
    Presenter: Jino Park, MD – University of California Irvine
  • 10:45 AM - 12:00 PM ET
    2588 - Benefit of Reirradiation in Recurrent Glioblastoma after Temozolomide-Based Chemoradiation: A Secondary and Updated Analysis of the [BLINDED] Study
    Location: Hall C
    Presenter: Sangjoon Park, MD, PhD – Yonsei University Health System
  • 10:45 AM - 12:00 PM ET
    2589 - Impact of Tumor Volume on Survival in Patients with Five or More Brain Metastases Undergoing Stereotactic Radiosurgery
    Location: Hall C
    Presenter: Melisa Pasli, BS – Brody School of Medicine
  • 10:45 AM - 12:00 PM ET
    2590 - Pre-Operative Single Fraction vs. Fractionated Stereotactic Radiotherapy: A Single-Institution Analysis of 299 Resected Metastases
    Location: Hall C
    Presenter: Haley Perlow, MD – Case Western Reserve University/University Hospitals Cleveland Medical Center
  • 10:45 AM - 12:00 PM ET
    2591 - Standard Dose vs. Reduced Dose Single Fraction Preoperative Radiosurgery for Resected Brain Metastases: A PROPS-BM International Multicenter Cohort Study
    Location: Hall C
    Presenter: Roshan Prabhu, MD, MS – Southeast Radiation Oncology Group PA
  • 10:45 AM - 12:00 PM ET
    2592 - Stereotactic Body Radiotherapy for Oligometastatic and Oligoprogressive Breast Cancer: Insights from a Single-Institution
    Location: Hall C
    Presenter: Mohammed Qamber, MD – Bahrain Oncology Center
  • 10:45 AM - 12:00 PM ET
    2593 - Lung SBRT for Oligo to Poly-Metastatic Colorectal Cancer
    Location: Hall C
    Presenter: Kaili Ranta, MD, PhD, BS – UW Health Radiation Oncology
  • 10:45 AM - 12:00 PM ET
    2594 - Prognostic Factors in Radionecrosis Following Post-Operative Stereotactic Brain Radiation Therapy from a Multicentric Retrospective Analysis
    Location: Hall C
    Presenter: Nicolas Roquet
  • 10:45 AM - 12:00 PM ET
    2595 - Rapid Early Progression after Surgery for IDH-Wildtype Glioblastoma and the Importance of the Pre-Radiation Planning MRI
    Location: Hall C
    Presenter: Jonathan Sackett, MD – University of Cincinnati - Barrett Cancer Center
  • 10:45 AM - 12:00 PM ET
    2596 - The association between time to postoperative radiotherapy, local control, and symptomatic adverse radiation effect in patients with resected brain metastases
    Location: Hall C
    Presenter: Mia Salans, MD, BA, MAS – University of California San Francisco
  • 10:45 AM - 12:00 PM ET
    2597 - Association of ALPS-Index and Glymphatic Flow with Neurocognitive Changes in Patients Receiving Brain Irradiation: Secondary Analysis of a Prospective Study
    Location: Hall C
    Presenter: Anurag Saraf, MD – Brigham and Women's Hospital/Dana-Farber
  • 10:45 AM - 12:00 PM ET
    2598 - Hypofractionated IMRT for Oligometastatic or Oligoprogressive Cancer Not Amenable to SBRT
    Location: Hall C
    Presenter: Angela Sarkisian, MS – George Washington University
  • 10:45 AM - 12:00 PM ET
    2599 - Local and Marginal Failures in Spinal and Non-Spinal Osseous Metastases Receiving SBRT and Immunotherapy: A Secondary Analysis of Phase I Trials
    Location: Hall C
    Presenter: Lucas Serra, MD, MS – University of Chicago
  • 10:45 AM - 12:00 PM ET
    2600 - Evaluating Serum CXCL Levels as Potential Biomarkers in Glioblastoma: Observed Alteration with Concurrent Chemoirradiation in Upfront Management
    Location: Hall C
    Presenter: Andra Krauze, MD – National Cancer Institute NIH
  • 10:45 AM - 12:00 PM ET
    2601 - Off-Protocol Radiotherapy in Phase III Metastatic Solid Tumor Trials
    Location: Hall C
    Presenter: Alexander Sherry, MD – University of Texas MD Anderson Cancer Center
  • 10:45 AM - 12:00 PM ET
    2602 - Policy vs. Pandemic: Effects on Utilization of Shorter Radiation Regimens for Palliating Osseous Metastases
    Location: Hall C
    Presenter: Yangyang Shi, MD, BS – University of Arizona
  • 10:45 AM - 12:00 PM ET
    2603 - Stereotactic Body Radiation Therapy for Oligometastatic Non-Spine Bone Metastases: A Retrospective Two-Center Study
    Location: Hall C
    Presenter: Yurika Shindo, MD – Aichi Cancer Center Hospital
  • 10:45 AM - 12:00 PM ET
    2604 - Functional Interaction between Tribbles1 (TRIB1) Pseudokinase and PTEN Tumor Suppressor in GBM Tumorigenesis
    Location: Hall C
    Presenter: Karnika Singh, PhD, MBA – OSU CCC
  • 10:45 AM - 12:00 PM ET
    2605 - Treatment Time Effect on Prescription Dose in the Treatment of Vestibular Schwannomas
    Location: Hall C
    Presenter: Matthew Skinner, MS – Kaiser Permanente South San Francisco
  • 10:45 AM - 12:00 PM ET
    2607 - Occurrence of Rapid Early Progression (REP) and Rapid Early Response (RER) in Patients with Newly Diagnosed GBM Undergoing Resection and Immediate Post Resection Brachytherapy: A Preliminary Report fr
    Location: Hall C
    Presenter: Lindsey Sloan, MD, PhD – University of Minnesota
  • 10:45 AM - 12:00 PM ET
    2608 - Stereotactic Body Radiation Therapy for Liver Oligometastases in Pancreatic Cancer: Enhancing Precision and Outcomes
    Location: Hall C
    Presenter: Fady Sourial, DO – Allegheny Health Network
  • 10:45 AM - 12:00 PM ET
    2609 - Dosimetric Comparison between Photon and Proton Stereotactic Radiosurgery for Cerebral Arteriovenous Malformations: A Single Institution Experience
    Location: Hall C
    Presenter: Will Sperduto, MD – Mayo Clinic Arizona
  • 10:45 AM - 12:00 PM ET
    2610 - Dose Escalation with Simultaneously Integrated Boost Followed by Cyberknife Boost(SIB-CK) with BEVULTRA-100 in Newly Diagnosed Glioblastoma Multiformae (GBM): A Real World Data Analysis
    Location: Hall C
    Presenter: Papaiah Susheela Sridhar, MD – Healthcare Global Enterprises Ltd.
  • 10:45 AM - 12:00 PM ET
    2611 - Stereotactic Radiation Therapy to Extracranial Sites of Symptomatic vs. Asymptomatic Metastatic Disease
    Location: Hall C
    Presenter: Ethan Steele, MD, MS – University of North Carolina at Chapel Hill
  • 10:45 AM - 12:00 PM ET
    2612 - Evaluating the Inter-Planner Contouring Variation in GRID Placement for Spatially Fractionated Radiation Therapy
    Location: Hall C
  • 10:45 AM - 12:00 PM ET
    2613 - Therapeutic and Prognostic Impact of Target Volume Delineation in Postoperative Radiotherapy for High-Grade Glioblastoma Patients with Subventricular Zone Involvement
    Location: Hall C
    Presenter: Fei Sun
  • 10:45 AM - 12:00 PM ET
    2615 - Systemic Inflammation Biomarkers are Prognostic Factors in Palliative Radiation Therapy for Stage IV Lung Cancer
    Location: Hall C
    Presenter: Hidekazu Tanaka, MD, PhD – Yamaguchi University Graduate School of Medicine
  • 10:45 AM - 12:00 PM ET
    2616 - Presentation and Outcomes for Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Melanoma Presenting with Leptomeningeal Disease at the Time of Initial Central Nervous System Involvement
    Location: Hall C
    Presenter: Ryan Tang, BA – University of South Florida College of Medicine
  • 10:45 AM - 12:00 PM ET
    2617 - Prospective Study of All Sensations Patients Experience While Proton or Photon External Beams Are on
    Location: Hall C
    Presenter: Sara Teplow, BA – University of Washington
  • 10:45 AM - 12:00 PM ET
    2618 - Risk of Radiation Necrosis after Stereotactic Radiosurgery with and without Immune Checkpoint Inhibition in Patients with NSCLC Brain Metastases in Eloquent Locations
    Location: Hall C
    Presenter: Andre Thomas, MD – University of Chicago
  • 10:45 AM - 12:00 PM ET
    2619 - Long-Term Outcomes of Single-Fraction Stereotactic Ablative Radiotherapy (SAbR) Using a Simultaneous-Integrated Boost (SIB) Approach for the Treatment of de Novo Spinal Metastases
    Location: Hall C
    Presenter: Brett Tortelli, MD, PhD – UT Southwestern Medical Center
  • 10:45 AM - 12:00 PM ET
    2620 - Radiation Therapy Oncology Group 8502 "QUAD Shot" Regimen Using Volumetric Modulated Arc Radiotherapy for Incurable Head and Neck Cancer
    Location: Hall C
    Presenter: Ryo Toya, MD, PhD – Nagasaki University
  • 10:45 AM - 12:00 PM ET
    2621 - Robotic Radiosurgery for the Treatment of Pediatric Arteriovenous Malformations
    Location: Hall C
    Presenter: Teeradon Treechairusame, MD – Memorial Sloan Kettering Cancer Center
  • 10:45 AM - 12:00 PM ET
    2622 - Postoperative Treatment for Metastatic Brain Metastases from Non-Small Cell Lung Cancer after Intracranial Tumor Resection: A Multi-Institutional Retrospective Study
    Location: Hall C
    Presenter: Megumi Uto, MD, PhD – Kyoto University Graduate School of Medicine
  • 10:45 AM - 12:00 PM ET
    2623 - Patterns of Care of Brain Metastasis for Non-Small Cell Lung Cancer (NSCLC) in the Era of Immunotherapy
    Location: Hall C
    Presenter: Sunitha Varghese, MD, MBBS – University of Kansas Medical Center
  • 10:45 AM - 12:00 PM ET
    2624 - Clinical Outcomes of Stereotactic Body Radiotherapy for Spinal Metastases with Paraspinal Extension
    Location: Hall C
    Presenter: Neil Vuppala, BA – Alabama College of Osteopathic Medicine
  • 10:45 AM - 12:00 PM ET
    2625 - Radiotherapy Combined with Pyrotinib Plus Capecitabine in Patients with Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer and Brain Metastases: A Single-Arm, Exploratory Trial
    Location: Hall C
    Presenter: Jing Wang, MD – Tianjin Cancer Hospital
  • 10:45 AM - 12:00 PM ET
    2626 - Postoperative Radiotherapy for Malignant Cord Compression Treated in a Public and Private Hospital
    Location: Hall C
    Presenter: Jonathan Wang, BS – University of Southern California Keck School of Medicine
  • 10:45 AM - 12:00 PM ET
    2627 - Spatially Fractionated Radiotherapy GRID for Bulky Tumor: A Large Single Institution Experience
    Location: Hall C
    Presenter: Kaidi Wang, MD – University of Arkansas for Medical Sciences (UAMS)
  • 10:45 AM - 12:00 PM ET
    2628 - Prediction Study of Prognostic Nutrition Index on the Nausea and Vomiting of Patients with Cancer Undergoing Chemotherapy or Concurrent Chemoradiotherapy Based on Cisplatin
    Location: Hall C
    Presenter: Lili Wang, BS
  • 10:45 AM - 12:00 PM ET
    2629 - Optimizing Glioblastoma Radioimmunotherapy through Peptide-Based Immuno-PET/CT: Monitoring PD-L1 Upregulation Post-Radiation
    Location: Hall C
    Presenter: Yong Wang
  • 10:45 AM - 12:00 PM ET
    2630 - The Role MRI Perfusion Scans with Carbon Fiber Reinforced PEEK for SBRT Planning Post Spinal Fusion
    Location: Hall C
    Presenter: Vikram Chakravarthy, MD – The Ohio State University James Cancer Hospital
  • 10:45 AM - 12:00 PM ET
    2631 - Carbon Fiber-PEEK Allows for Earlier Detection of Tumor Recurrence Compared to Titanium Instrumentation: A Comparative Study
    Location: Hall C
    Presenter: Vikram Chakravarthy, MD – The Ohio State University James Cancer Hospital
  • 10:45 AM - 12:00 PM ET
    2632 - Biological Effective Dose-Based Fractionated Stereotactic Radiation Therapy for Brain Metastasis in the New Era: A Retrospective Multi-Institution Study
    Location: Hall C
    Presenter: Takahiro Watakabe, MD, PhD – Kumamoto University
  • 10:45 AM - 12:00 PM ET
    2633 - Different Detection Rates of Brain Metastasis in Different Pathological Types of Lung Cancer by 18F-FAPI PET/CT
    Location: Hall C
    Presenter: Yuchun Wei, MD, PhD – Shandong Cancer Hospital and Institute
  • 10:45 AM - 12:00 PM ET
    2634 - A Pilot Phase 2 Study Evaluating Dose De-Escalation in Whole Brain Radiation Therapy with Simultaneous Integrated Boost for Patients with Brain Metastases
    Location: Hall C
    Presenter: Michael Weisman, MD – IU Health Methodist Hospital
  • 10:45 AM - 12:00 PM ET
    2635 - Radiation Dose Fractionations for Malignant Spinal Cord Compression in Patients Not Eligible for Surgery: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
    Location: Hall C
    Presenter: Shing Fung Lee, MBBS – National University Hospital
  • 10:45 AM - 12:00 PM ET
    2635 - Radiation Dose Fractionations for Malignant Spinal Cord Compression in Patients Not Eligible for Surgery: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
    Location: Hall C
    Presenter: Henry Wong, MBBS – Princess Margaret Hospital Hong Kong
  • 10:45 AM - 12:00 PM ET
    2636 - Can Individualized Dosimetry Improve Treatment Efficacy for 177Lu-DOTATATE (D) Therapy in Primary Site Agnostic Neuroendocrine Tumors?
    Location: Hall C
    Presenter: Rebecca Wong, MB, ChB, MS – Princess Margaret Cancer Centre
  • 10:45 AM - 12:00 PM ET
    2637 - The Eurytopic Paradigm of Simultaneous Integrated Boost Volumetric Modulated Arc Radiotherapy for Brain Metastases: A Phase Ib/II Clinical Trial
    Location: Hall C
    Presenter: Mingyao Wu, MD – Fudan University Shanghai Cancer Center
  • 10:45 AM - 12:00 PM ET
    2638 - A Predictive Nomogram for Long-Term Outcomes of High-Grade Meningiomas Undergoing Postoperative Radiotherapy
    Location: Hall C
    Presenter: Tianqi Wu, PhD
  • 10:45 AM - 12:00 PM ET
    2639 - Modeling of Out-of-Pocket Costs across Medicaid and Medicare Plans of Standard-of-Care External Beam Radiation Therapy vs. Radiosurgery for Symptomatic Metastatic Spine Cancer
    Location: Hall C
    Presenter: Victoria Wu, BA – Case Western Reserve School of Medicine
  • 10:45 AM - 12:00 PM ET
    2640 - Modeling of Out-Of-Pocket Costs Across Medicaid and Medicare Plans of Standard-of-Care Radiosurgery Duration for Metastatic Spine Cancer
    Location: Hall C
    Presenter: Victoria Wu, BA – Case Western Reserve School of Medicine
  • 10:45 AM - 12:00 PM ET
    2641 - Whole-Brain Radiation Therapy with Simultaneous Integrated Boost vs. Stereotactic Radiotherapy for the Treatment of Brain Metastasis from Non-Small Cell Lung Cancer
    Location: Hall C
    Presenter: Ziwei Wu
  • 10:45 AM - 12:00 PM ET
    2642 - Complete Epidural Decompression Combined with Spine Radiosurgery in High-Grade Epidural Spinal Cord Compression (ESCC): A Dosimetric and Outcome Analysis
    Location: Hall C
    Presenter: Yen-Ruh Wuu, MD – Northwell Health
  • 10:45 AM - 12:00 PM ET
    2643 - Efficacy and Safety of Enzyme-Cleavable EGFR-MMAE Combined with Radiotherapy in Treating GBM: A Preclinical Phase Study
    Location: Hall C
    Presenter: Yun Xing, BS – Tianjin University
  • 10:45 AM - 12:00 PM ET
    2645 - Development of a Machine Learning-Based Tool to Predict Local Failure after Stereotactic Radiosurgery for Small Brain Metastases
    Location: Hall C
    Presenter: Sreenija Yarlagadda, MD – Miami Cancer Institute
  • 10:45 AM - 12:00 PM ET
    2646 - Advanced MRI and 18F-DOPA PET/CT and Their Impact on Radiotherapy Target Volumes in Glioblastoma
    Location: Hall C
    Presenter: Eyesha Younus, PhD – Mayo Clinic
  • 10:45 AM - 12:00 PM ET
    2647 - MDM2 Inhibition and the Efficacy of Radiotherapy and PD-L1 Antibody Combination Therapy by Reprogramming the Glioblastoma Tumor Microenvironment
    Location: Hall C
    Presenter: Chunhui Yuan, BS
  • 10:45 AM - 12:00 PM ET
    2648 - Prognostic Factors for Local Failure and Overall Survival in Patients with Epidural Disease at the Cauda Equina Following Stereotactic Body Radiotherapy: A Clinical, Anatomic and Dosimetric Analysis
    Location: Hall C
    Presenter: Sondos Zayed, MD, MPH, FRCPC – University of Ottawa at The Ottawa Hospital
  • 10:45 AM - 12:00 PM ET
    2649 - Stereotactic Radiotherapy vs. Whole Brain Radiation Therapy in EGFR Mutated NSCLC: Results and Reflections from the Prematurely Closed Phase III HYBRID Trial
    Location: Hall C
    Presenter: Ming Zeng, MD, PhD – Sichuan Taikang Hospital
  • 10:45 AM - 12:00 PM ET
    2650 - Clinical Outcomes Following Stereotactic Radiosurgery in Breast Cancer Brain Metastasis with or without Systemic Metastasis
    Location: Hall C
    Presenter: Dekuang Zhao, DO, PhD – Moffitt Cancer Center
  • 10:45 AM - 12:00 PM ET
    2651 - Long-Term Outcomes Following Stereotactic Radiosurgery and Radiotherapy for Benign Skull Base Meningioma
    Location: Hall C
    Presenter: Nancy Zhou, MD – Kaiser Permanente Los Angeles Medical Center
  • 3:00 PM - 4:00 PM ET
    2652 - Analysis of Failure Risk Factors in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy: A Large Cohort Retrospective Study
    Location: Hall C
    Presenter: George Naoum, MD, MS – Northwesrn Memorial Hospital
  • 3:00 PM - 4:00 PM ET
    2653 - Exploration of Flap-Protected Hypofractionated Radiotherapy in Patients with Locally Advanced Autologous Reconstructive Breast Cancer
    Location: Hall C
    Presenter: Muyasha Abulimiti, MD, dr – National Clinical Research Center for Cancer/Cancer Hospital
  • 3:00 PM - 4:00 PM ET
    2654 - Over Treatment of Stage I, Node-Negative, Hormone-Sensitive Breast Cancer? Analysis of Techniques and Doses at a Comprehensive Cancer Center with Community Network Affiliates
    Location: Hall C
    Presenter: Jose Bazan, MD, MS – City of Hope Comprehensive Cancer Center
  • 3:00 PM - 4:00 PM ET
    2656 - Smoking History and Breast Shrinkage Following Breast Conserving Treatment and Radiation Therapy
    Location: Hall C
    Presenter: Miriam Becker, MS – UC San Diego School of Medicine
  • 3:00 PM - 4:00 PM ET
    2657 - Comparison between Proton LET-Dependent RBE Dose and Photon Physical Dose for Acute Radiation Dermatitis in Caucasian and African-American Breast Cancer Patients Undergoing Radiation Therapy
    Location: Hall C
    Presenter: Nrusingh Biswal, PhD, DABR – University of Maryland School of Medicine, Baltimore
  • 3:00 PM - 4:00 PM ET
    2658 - Rare but Relevant: Exploring Factors behind the Exclusion of Inflammatory Breast Cancer from Breast Cancer Clinical Trials
    Location: Hall C
    Presenter: Erica Braschi Jordan, MD – University of Florida
  • 3:00 PM - 4:00 PM ET
    2659 - Beyond Traditional Borders: Outcomes with Curative Intent Therapy for Stage IV Breast Cancer Defined by Non-Regional Nodal Metastases
    Location: Hall C
    Presenter: Erica Braschi Jordan, MD – University of Florida
  • 3:00 PM - 4:00 PM ET
    2660 - Post-Lumpectomy Radiation Therapy and Patient-Reported Shoulder Function: A Dosimetric Analyses of the Shoulder Skeletal Muscles
    Location: Hall C
    Presenter: Renata Braudy, PhD, MS, OCS, CLT – University of Minnesota Department of Radiation Oncology and Twin Cities Orthopedics
  • 3:00 PM - 4:00 PM ET
    2661 - Accelerated Partial Breast Irradiation for Patients with Invasive Lobular Carcinoma
    Location: Hall C
    Presenter: Lior Braunstein, MD – Memorial Sloan Kettering Cancer Center
  • 3:00 PM - 4:00 PM ET
    2662 - Trends in Incidence, Treatment Patterns and Genomic Testing Utilization among Male Breast Cancer Patients Using the OneFlorida Database
    Location: Hall C
    Presenter: Anthony Casper, DO – University of Florida Shands Cancer Center
  • 3:00 PM - 4:00 PM ET
    2663 - Breast Cancer-Related Lymphedema Quantified by Bioimpedance Spectroscopy in Patients Undergoing Axillary Node Dissection, Lymphatic Microsurgical Preventive Healing Approach (LYMPHA) and Regional Noda
    Location: Hall C
    Presenter: Danielle Cerbon, MD – University of Miami
  • 3:00 PM - 4:00 PM ET
    2664 - Cardiopulmonary Substructure Doses are Not Correlated with Cardiorespiratory Fitness among Breast Cancer Survivors Treated with Contemporary Radiotherapy
    Location: Hall C
    Presenter: Laura Cervino, PhD – Memorial Sloan Kettering Cancer Center
  • 3:00 PM - 4:00 PM ET
    2665 - Ultra-Hypofractionated Whole Breast Radiation Therapy Using a Novel Boost Regimen for Early-Stage Breast Cancer
    Location: Hall C
    Presenter: Molly Chakraborty, BSE – Rutgers New Jersey Medical School
  • 3:00 PM - 4:00 PM ET
    2666 - Reconstructive Outcomes and Complications after Mastectomy and Proton Therapy for Breast Cancer
    Location: Hall C
    Presenter: Molly Chakraborty, BSE – Rutgers New Jersey Medical School
  • 3:00 PM - 4:00 PM ET
    2667 - The Impact of Immune Microenvironment on Local Control of Breast Ductal Carcinoma In Situ Receiving Breast Conservative Therapy
    Location: Hall C
    Presenter: Jia-Yi Chen, PhD
  • 3:00 PM - 4:00 PM ET
    2668 - Investigation of the Optimal Design of the Low Dose Radiotherapy Machine for the Osteoarthritis Based on the Monte Carlo Simulation
    Location: Hall C
    Presenter: Chang Heon Choi, PhD – Seoul National University Hospital
  • 3:00 PM - 4:00 PM ET
    2669 - Photon vs. Proton Post-Mastectomy Radiotherapy Toxicities in Pre-Pectoral Implant-Based Breast Reconstruction
    Location: Hall C
    Presenter: Seraphina Choi, MD – University of Miami Miller School of Medicine
  • 3:00 PM - 4:00 PM ET
    2670 - Stereotactic Radiotherapy (SRT) with Maintenance Systemic Therapy vs. Standard-of-Care (SOC) Systemic Therapy for Oligoprogressive ER-Positive, HER2-Negative Breast Cancer (AVATAR II)
    Location: Hall C
    Presenter: Emma Connolly, MB, BCH BAO MRCPI – Peter MacCallum Cancer Centre
  • 3:00 PM - 4:00 PM ET
    2671 - Final Results from the SAVE-HEART Study - Surface-Based Deep Inspiration Breath-Hold Radiotherapy in Left-Sided Breast Cancer
    Location: Hall C
    Presenter: Stefanie Corradini, MD – LMU Munich
  • 3:00 PM - 4:00 PM ET
    2672 - Impact of Consensus Guidelines, Clinical Trials and COVID 19 on Fractionation Practices for Node Negative Intact Breast Cancer
    Location: Hall C
    Presenter: Jessica Cruttenden, MD – Huntsman Cancer Institute at the University of Utah
  • 3:00 PM - 4:00 PM ET
    2673 - Factors Influencing the Utilization of the Integrated Magnetic Resonance Linac for Accelerated Partial Breast Irradiation
    Location: Hall C
    Presenter: Jenna Dean, RT – Olivia Newton John Cancer & Wellness Centre
  • 3:00 PM - 4:00 PM ET
    2674 - Real-Life Impact of Hypofractionated IMRT in Early Breast Cancer on Cardiovascular Risk
    Location: Hall C
    Presenter: Ana Aurora Diaz-Gavela, MD – Hospital Universitario Quiron Madrid
  • 3:00 PM - 4:00 PM ET
    2675 - Prospective Evaluation of Acute Toxicity from Tumor Bed Boost Following Whole Breast Radiotherapy
    Location: Hall C
    Presenter: Michael Dykstra, MD – University of Michigan
  • 3:00 PM - 4:00 PM ET
    2676 - Do Standard Tangents Cover High-Risk Nodes among Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy?
    Location: Hall C
    Presenter: Madeline Flanagan, MD – Baylor College of Medicine
  • 3:00 PM - 4:00 PM ET
    2677 - Novel Use of SCOUT® Reflector for Target Localization in Preoperative Breast Radiotherapy
    Location: Hall C
    Presenter: Nader Ghassemi, PhD – Thomas Jefferson University
  • 3:00 PM - 4:00 PM ET
    2678 - Safety of Concurrent Administration of TDM1 and Radiotherapy in Patients with HER2+ Breast Cancer with Residual Disease Post-Neoadjuvant Chemotherapy
    Location: Hall C
    Presenter: Laura Girres, MD
  • 3:00 PM - 4:00 PM ET
    2679 - Improving Breast Cancer Quality Metrics with Early Radiation Oncology Internal Referral Model
    Location: Hall C
    Presenter: Ronald Goldsberry, BS – Baylor College of Medicine
  • 3:00 PM - 4:00 PM ET
    2680 - Long Term Single Institution Clinical Outcomes for Locally Recurrent Breast Cancer Patients Treated with a Second Breast Conserving Surgery and Intraoperative Radiotherapy
    Location: Hall C
    Presenter: Fabiana Gregucci, MD – Weill Cornell Medicine
  • 3:00 PM - 4:00 PM ET
    2681 - Heart and Left Anterior Descending Coronary Artery (LAD) Exposure from Hypo-Fractionated Whole Breast Radiotherapy with a Prone Set Up
    Location: Hall C
    Presenter: Fabiana Gregucci, MD – Weill Cornell Medicine
  • 3:00 PM - 4:00 PM ET
    2682 - Dosimetric and Clinical Data from Linac-Based Stereotactic Arrhythmia Radioablation
    Location: Hall C
    Presenter: Fabiana Gregucci, MD – Weill Cornell Medicine
  • 3:00 PM - 4:00 PM ET
    2683 - Ultra-Hypofractionated Radiation in Older Patients with Low Risk Early-Stage Breast Cancer
    Location: Hall C
    Presenter: Bin Gui, MD, MS – Northwell Health
  • 3:00 PM - 4:00 PM ET
    2684 - Predicting Cardiotoxicity after Breast Cancer Radiotherapy Utilizing Dosimetry and Imaging
    Location: Hall C
    Presenter: Felicia Guo, BA – Strong Memorial Hospital
  • 3:00 PM - 4:00 PM ET
    2685 - Effectiveness of Hypofractionated Radiotherapy in Microinvasive Breast Cancer
    Location: Hall C
    Presenter: Camille Hardy Abeloos, MD – NYU Grossman School of Medicine
  • 3:00 PM - 4:00 PM ET
    2686 - Relationship of Immediate Breast Reconstruction and the Development of Lymphedema in Breast Cancer Patients with Radiotherapy
    Location: Hall C
    Presenter: Soon Woo Hong, MD – Seoul National University Hospital
  • 3:00 PM - 4:00 PM ET
    2687 - Complications of Implant-Based Reconstruction and Post-Mastectomy Radiation in the Era of Adjuvant CDK4/6 Inhibitors
    Location: Hall C
    Presenter: Hamail Iqbal, BS – Cooper Medical School of Rowan University
  • 3:00 PM - 4:00 PM ET
    2688 - Locoregional Recurrence and Survival Outcome of HER2-Low Breast Cancer Patients after Upfront Surgery and Adjuvant Radiotherapy
    Location: Hall C
  • 3:00 PM - 4:00 PM ET
    2689 - Early Results of a Phase II Trial of Ultra-hypofractioNated Adjuvant Radiotherapy ± sImultaneous Integrated Boost for Low-risk Breast Cancer Patients (UNIQUE)
    Location: Hall C
    Presenter: Hao Jing, MD – CAMS
  • 3:00 PM - 4:00 PM ET
    2690 - Early Results of a Prospective Study of Preoperative Tumor-Bed Boost Followed by Oncoplastic Surgery and Adjuvant Whole Breast Radiotherapy for Early-Stage Breast Cancer
    Location: Hall C
    Presenter: Hao Jing, MD – CAMS
  • 3:00 PM - 4:00 PM ET
    2691 - Predictors of Acute Skin Toxicity in Patients Undergoing Hypofractionated Adjuvant Whole Breast Radiotherapy with VMAT or Helical Tomotherapy
    Location: Hall C
    Presenter: Didem Karacetin, MD – Health Science University, Basaksehir Cam and Sakura City Hospital
  • 3:00 PM - 4:00 PM ET
    2692 - Analysis of Patient Reported Outcomes in the Prevention of Acute Radiation Dermatitis with Topical Therapies
    Location: Hall C
    Presenter: Aria Kieft, MD – Michigan Radiation Oncology Consultants
  • 3:00 PM - 4:00 PM ET
    2693 - Contemporary Trends in Radiation Protocols for Breast Cancer Treatment: A Population-Based Analysis
    Location: Hall C
    Presenter: Gary Ko, MD – Princess Margaret Cancer Center, University Health Network
  • 3:00 PM - 4:00 PM ET
    2694 - Reconstruction Complications and Oncologic Outcomes Among Women Treated with Nipple or Skin Sparing Mastectomy and Adjuvant Radiation
    Location: Hall C
    Presenter: Sravya Koduri, MD, BS – NYU Langone Health
  • 3:00 PM - 4:00 PM ET
    2695 - Low Dose Radiation Therapy for Osteoarthritis: A Retrospective Single Institution Analysis of 51 Patients and 85 Joints
    Location: Hall C
    Presenter: Nagendra (Bobby) Koneru, MD, FASTRO – FHN Memorial Hospital
  • 3:00 PM - 4:00 PM ET
    2696 - Serial Quality-of-Life Scores Following Ultrahypofractionated Radiotherapy (UHFRT) and Simultaneous Integrated Boost (SIB) Post Breast Conserving Surgery: Largest Real-World Data of a Prospectively Fo
    Location: Hall C
    Presenter: Revathy Krishnamurthy, MD – ACTREC, TMC
  • 3:00 PM - 4:00 PM ET
    2697 - Unveiling Patient and Provider Perceptions on Medical Tattoos in Breast Cancer Radiotherapy
    Location: Hall C
    Presenter: Grace Lee, RT, MHSc – Princess Margaret Cancer Centre
  • 3:00 PM - 4:00 PM ET
    2698 - Development and Validation of a Prediction Model for Major Adverse Cardiac Events in Patients with Hepatocellular Carcinoma Undergoing Stereotactic Body Radiation Therapy
    Location: Hall C
    Presenter: Hye In Lee, MD – Seoul National University Hospital
  • 3:00 PM - 4:00 PM ET
    2699 - Re-Irradiation Toxicity and Survival Outcomes for Locoregionally Recurrent or New Ipsilateral Breast Cancer
    Location: Hall C
    Presenter: Kamaria Lee, MD, AB – MD Anderson Cancer Center
  • 3:00 PM - 4:00 PM ET
    2700 - Risk Factors of Radiation Pneumonitis in Breast Cancer with Internal Mammary Chain Irradiation
    Location: Hall C
    Presenter: Sang Min Lee – Seoul National University College of Medicine
  • 3:00 PM - 4:00 PM ET
    2701 - Long-Term Outcomes of a Phase I/II Trial for Stereotactic Arrhythmia Radioablation in Ventricular Tachycardia
    Location: Hall C
    Presenter: Jing Li, MD
  • 3:00 PM - 4:00 PM ET
    2702 - Daily Online Adaptive Radiotherapy with Narrow Margins for Ultra-Hypofractionated Whole Breast Irradiation (A-FF-WBI): Dosimetry and Early Clinical Outcomes
    Location: Hall C
    Presenter: Xingzhe Li, MD, MPH – UT Southwestern Medical Center
  • 3:00 PM - 4:00 PM ET
    2703 - Diagnostic Value of 18F-FAPI-04 PET/CT for Identification of Benign Breast Lesions and Breast Cancers: Comparison with Traditional Imaging Examinations
    Location: Hall C
    Presenter: Jingru Liu, MD
  • 3:00 PM - 4:00 PM ET
    2704 - Treatment Implications of Low Compliance with Endocrine Therapy for Older Women with Early-Stage Breast Cancer
    Location: Hall C
    Presenter: Maryanne Lubas, DO – Fox Chase Cancer Center
  • 3:00 PM - 4:00 PM ET
    2705 - Dosimetric Comparison of Simultaneous Integrated Boost Using Field-in-Field IMRT vs. Hybrid VMAT vs. Ring Gantry VMAT for Left-Sided Breast Cancers
    Location: Hall C
    Presenter: Beela Sarah Mathew, MD – Regional Cancer Centre
  • 3:00 PM - 4:00 PM ET
    2706 - Low-Dose Radiotherapy for Heel Spur Treatment: A Retrospective Study of Efficacy and Safety
    Location: Hall C
    Presenter: Christiane Matuschek, MD – University of Duesseldorf
  • 3:00 PM - 4:00 PM ET
    2707 - Impact of COVID on Utilization of Ultra-Hypofractionation in Breast Cancer Treatment
    Location: Hall C
    Presenter: Riley McDougall, MD – University of Arizona
  • 3:00 PM - 4:00 PM ET
    2708 - Impact of COVID on Utilization of Hypofractionation in Node-Positive Breast Cancer Treatment
    Location: Hall C
    Presenter: Jonathan Gabriel, DO, MS – University of Arizona College of Medicine Tucson
  • 3:00 PM - 4:00 PM ET
    2709 - A New Method for Breast Cancer Classification: Comprehensive Application of Latent Class Analysis in Clinical and Genetic Expression Information
    Location: Hall C
    Presenter: Qingyu Meng, MD, PhD, RT – Peking Union Medical College Hospital
  • 3:00 PM - 4:00 PM ET
    2710 - Long-Term Complete Response Rates of Arteriovenous Malformations Treated with LINAC-Based Stereotactic Radiosurgery
    Location: Hall C
    Presenter: Hari Menon, MD, BS – University of Wisconsin Radiation Oncology
  • 3:00 PM - 4:00 PM ET
    2711 - Palliative Radiotherapy in Breast Cancer with Skin Involvement
    Location: Hall C
    Presenter: Sunho Min, MD – Yonsei Cancer Center
  • 3:00 PM - 4:00 PM ET
    2712 - Comparing Protons vs. Photons on Breast Reconstruction Outcomes and Dosimetry Analysis
    Location: Hall C
    Presenter: George Naoum, MD, MS – Northwesrn Memorial Hospital
  • 3:00 PM - 4:00 PM ET
    2713 - Cardiac Events and Dynamic Echocardiogram Changes in Low Cardiovascular Risk Patients with Triple Negative Breast Cancer Treated with Immunotherapy
    Location: Hall C
    Presenter: Jean Philippe Nesseler, MD, MS – Cedars-Sinai Medical Center
  • 3:00 PM - 4:00 PM ET
    2714 - The Impact of a Bra upon Inframammary Skin Fold Measurements for Large-Breasted Women, Positioned Upright
    Location: Hall C
    Presenter: Jemma Nunn, RT – Leo Cancer Care
  • 3:00 PM - 4:00 PM ET
    2715 - Preliminary Results of a Phase I Trial Using Preoperative Stereotactic Ablative Breast Radiotherapy (SABER) for Selected Early-Stage Breast Cancer
    Location: Hall C
    Presenter: Ifeanyichukwu Ogobuiro, MD, MS – University of Miami Sylvester Comprehensive Cancer Center
  • 3:00 PM - 4:00 PM ET
    2716 - Safety and Efficacy of Hypofractionated Radiation Therapy in Patients who undergo Post mastectomy Radiation Therapy
    Location: Hall C
    Presenter: Oluwatimileyin Ojo, MD – Northwell Health
  • 3:00 PM - 4:00 PM ET
    2717 - Cosmetic Outcomes Following Whole Breast or Partial Breast Radiation Therapy for Breast Cancer: A Single Institutional Experience
    Location: Hall C
    Presenter: Anna Okabe, BS – California Northstate University College of Medicine
  • 3:00 PM - 4:00 PM ET
    2718 - Targeting Accuracy of Frameless Linear Accelerator Thalamotomy
    Location: Hall C
    Presenter: Richard Popple, PhD – University of Alabama at Birmingham
  • 3:00 PM - 4:00 PM ET
    2719 - The PREDICT II Registry: A Prospective Study to Evaluate the Clinical Utility of a 7-Gene Predictive Biosignature on Treatment Decisions in Patients with Ductal Carcinoma In Situ
    Location: Hall C
    Presenter: Rachel Rabinovitch, MD, FASTRO – University of Colorado Denver
  • 3:00 PM - 4:00 PM ET
    2720 - Multi-Institutional Phase II Trial Using Dose Escalated Five Fraction Stereotactic Partial Breast Irradiation (S-PBI) with a Cobalt Stereotactic Unit for Early Stage Breast Cancer
    Location: Hall C
    Presenter: Asal Rahimi, MD, MS – University of Texas Southwestern Medical Center
  • 3:00 PM - 4:00 PM ET
    2721 - Early Outcomes of Accelerated Partial Breast Irradiation with Interstitial Brachytherapy vs. Extreme Hypo-Fractionated EBRT in Indian Females with Early Breast Cancer - A Randomized Controlled Trial
    Location: Hall C
    Presenter: Daya Nand Sharma, MD – AIIMS New Delhi
  • 3:00 PM - 4:00 PM ET
    2722 - Ultra-Hypofractionated One-Week Locoregional Radiation for Early Breast Cancer: Dose Distribution to Target Volumes and Organs-at-Risk
    Location: Hall C
    Presenter: Ivica Ratosa, MD, PhD – Institute of Oncology Ljubljana
  • 3:00 PM - 4:00 PM ET
    2723 - Complications of Post-Mastectomy Radiotherapy in Immediate Two-Stage Implant Reconstruction: Contemporary Outcomes at an Academic Hospital System
    Location: Hall C
    Presenter: Matthew Riina, MD – Hospital of the University of Pennsylvania
  • 3:00 PM - 4:00 PM ET
    2725 - Partial Breast Radiation Outcomes and Toxicity for Women with Early Breast Cancer in a Large Community Based Practice
    Location: Hall C
    Presenter: Michael Karp, MD – Maimonides Cancer Center
  • 3:00 PM - 4:00 PM ET
    2726 - Obliteration Rates for High-Risk Arteriovenous Malformations with Dose-Escalated Hypofractionated Radiosurgery
    Location: Hall C
    Presenter: Sophia Shah, BS
  • 3:00 PM - 4:00 PM ET
    2727 - Clinical Outcomes in Breast Cancer Patients with Underlying Germline PALB2 Mutations Treated with Radiation .
    Location: Hall C
    Presenter: Ahmed Shalaby, MD – CINJ/RWJ
  • 3:00 PM - 4:00 PM ET
    2728 - Impact of Strength Training on Metabolism, Body Composition, Strength and Mobility during Adjuvant Radiotherapy for Breast Cancer
    Location: Hall C
    Presenter: Parisa Shamsesfandabadi, MD – Allegheny Health Network
  • 3:00 PM - 4:00 PM ET
    2729 - Predictors of Survival in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy, Surgery, and Radiotherapy
    Location: Hall C
    Presenter: Shali Shao, MS – Fudan University Shanghai Cancer Center
  • 3:00 PM - 4:00 PM ET
    2730 - Involved Quadrant Irradiation (IQI) Post Breast Conservation Surgery: Preliminary Results of Ongoing Phase 3 Randomized Controlled Trial
    Location: Hall C
    Presenter: Daya Nand Sharma, MD – AIIMS New Delhi
  • 3:00 PM - 4:00 PM ET
    2731 - Postoperative Breast Radiation Therapy Using Deformable Image Registration of Initial PET/CT in the Same Posture before Primary Systemic Therapy: Does PET-Based Precise Planning Translate into a Clini
    Location: Hall C
    Presenter: Kenshiro Shiraishi, MD, PhD – Teikyo University
  • 3:00 PM - 4:00 PM ET
    2732 - Evolution of Radiotherapy Options for Elderly Patients with Early Stage ER+ Breast Cancer: A 10 Year Review
    Location: Hall C
    Presenter: Karin Skalina, MD, PhD – Montefiore Medical Center/Albert Einstein College of Medicine
  • 3:00 PM - 4:00 PM ET
    2733 - Large Tumor-Bed Boost Size and Cosmesis after Breast-Conserving Surgery and Whole Breast Irradiation: A Post Hoc Analysis of a Phase III Randomized Trial Comparing Hypofractionated and Conventional Fr
    Location: Hall C
    Presenter: Yuchun Song, MD – Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
  • 3:00 PM - 4:00 PM ET
    2735 - Evaluation of Cardiac Damage by Cardiac CT in Patients with Esophageal Cancer prior to Radiotherapy
    Location: Hall C
    Presenter: Akinori Takada, MD, PhD – Mie University Hospital
  • 3:00 PM - 4:00 PM ET
    2736 - Adoption of Hypofractionated and Ultrahypofractionated Adjuvant Radiation Therapy for Breast Cancer Treatment among Providers at a Large Academic Medical Center
    Location: Hall C
    Presenter: Leila Tchelebi, MD – Northern Westchester Hospital
  • 3:00 PM - 4:00 PM ET
    2737 - Thermal Dose-Effect on Locoregional Control in Locoregional Recurrent Breast Cancer Patients
    Location: Hall C
    Presenter: C. Paola Tello Valverde, MS – Amsterdam University Medical Center (AUMC)
  • 3:00 PM - 4:00 PM ET
    2738 - A Single-Institution Retrospective Review Intensity-Modulated Accelerated Partial Breast Irradiation Using a Radiopaque Filament and Breath-Hold to Facilitate Reduced CTV to PTV Margin
    Location: Hall C
    Presenter: Vincenzo Theobald – Inova Schar Cancer Institute
  • 3:00 PM - 4:00 PM ET
    2739 - Pre-Operative, Single Fraction Stereotactic Partial Breast Irradiation (S-PBI) for Early-Stage Breast Cancer: Radiology-Pathology Correlation of Tumor Response in a Phase 2 Clinical Trial
    Location: Hall C
    Presenter: Marco Trovo, MD – Asuiud Udine Hospital
  • 3:00 PM - 4:00 PM ET
    2740 - Lens-Sparing IMRT for the Management of Sturge-Weber Syndrome Associated Diffuse Choroidal Hemangiomas: An Institutional Experience
    Location: Hall C
    Presenter: Adannia Ufondu, MD, BA – Cleveland Clinic
  • 3:00 PM - 4:00 PM ET
    2741 - Radiation or Axillary Lymph Node Dissection after Positive Sentinel Lymph Node Biopsy Following Neoadjuvant Chemotherapy for Breast Cancer: A Retrospective Review
    Location: Hall C
    Presenter: Kathleen Waeldner, BA – Robert Larner, MD College of Medicine at the University of Vermont
  • 3:00 PM - 4:00 PM ET
    2742 - Simultaneous Integrated Tumor Bed Boost vs. Sequential Boost during Conventional Fractionated Whole-Breast Irradiation after Breast-Conserving Surgery
    Location: Hall C
    Presenter: Dan-Qiong Wang, MD – National Cancer Center/ National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Acade
  • 3:00 PM - 4:00 PM ET
    2743 - Simultaneous Integrated Tumor Bed Boost vs. Sequential Boost during Hypofractionated Whole-Breast Irradiation after Breast-Conserving Surgery
    Location: Hall C
    Presenter: Dan-Qiong Wang, MD – National Cancer Center/ National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Acade
  • 3:00 PM - 4:00 PM ET
    2744 - Study on Short-Term Complications and Quality of Life for Breast Cancer Patients Who Underwent Breast-Conserving Surgery Combined with Intraoperative Radiotherapy
    Location: Hall C
    Presenter: Jing Wang, MD – Tianjin Cancer Hospital
  • 3:00 PM - 4:00 PM ET
    2745 - Dosimetric Benefit and Clinical Feasibility of Deep Inspiratory Breath-Hold and Volumetric Modulated Arc Therapy Based Postmastectomy Radiotherapy for Left-Sided Breast Cancer
    Location: Hall C
    Presenter: Shijia Wang, MD
  • 3:00 PM - 4:00 PM ET
    2746 - Clinical Outcomes after Post-Operative Radiotherapy for Breast Cancer Patients Presenting with Ipsilateral Supraclavicular Metastasis: Considerations on the Cranial Border of Irradiation Field
    Location: Hall C
    Presenter: Xiaofang Wang, PhD – Fudan University Shanghai Cancer Center
  • 3:00 PM - 4:00 PM ET
    2747 - Is Proton Therapy for Synchronous Bilateral Breast Cancer a Medical Necessity?
    Location: Hall C
    Presenter: Cyrus Washington, MD, MS – University of Miami
  • 3:00 PM - 4:00 PM ET
    2748 - Predicting Radiation-Induced Acute Toxicity in Breast Cancer Patients: A Radiogenomic Approach
    Location: Hall C
    Presenter: Shouyi Wei – Rutgers Cancer Institute of New Jersey
  • 3:00 PM - 4:00 PM ET
    2749 - Accelerated Partial Breast Irradiation for Low-Risk Hormone-Sensitive Breast Cancer is Underutilized but Increasing in the National Cancer Database 2010-2021
    Location: Hall C
    Presenter: Jose Bazan, MD, MS – City of Hope Comprehensive Cancer Center
  • 3:00 PM - 4:00 PM ET
    2750 - Thoracic Anatomic Features Predict Benefit from Proton Therapy in Breast Cancer Patients: A Study Based on NTCP Model of Lung Toxicity
    Location: Hall C
    Presenter: Xiao-Yu Wu, MD
  • 3:00 PM - 4:00 PM ET
    2751 - Safety and Feasibility of Concurrent Abemaciclib and Postoperative Radiotherapy for Breast Cancer: A Real-World Analysis
    Location: Hall C
    Presenter: Liang Xuan
  • 3:00 PM - 4:00 PM ET
    2752 - Selection of Patients with Left Breast Cancer for DIBH Based on Three-Dimensional Dose Prediction
    Location: Hall C
    Presenter: Kun Zhang
  • 3:00 PM - 4:00 PM ET
    2753 - Radiotherapy Quality Assurance of the Ongoing Potential Phase III Randomized Controlled Trial Investigating the Role of Internal Mammary Lymph Node Irradiation for Breast Cancer: An Individual Case Re
    Location: Hall C
    Presenter: Xuran Zhao, MD – National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy
  • 3:00 PM - 4:00 PM ET
    2754 - Cardiac Dose and Injury after Radiotherapy in Patients with Postoperative Left-Sided Breast Cancer: A Cardiac Magnetic Resonance Study
    Location: Hall C
    Presenter: Jun Yin, MD – Sichuan Cancer Hospital and Institute
  • 3:00 PM - 4:00 PM ET
    2755 - Is the Strategy of Regional Nodal Irradiation (RNI) in cT1-2N0M0 Breast Patients with Limited Positive Sentinel Nodes (SLNs) Forgoing ALND Associated with the Risk of Non-SLNs Metastasis: A Multi-Cent
    Location: Hall C
    Presenter: Siyue Zheng, MD – Ruijin Hospital, Shanghai Jiaotong University School of Medicine
  • 3:00 PM - 4:00 PM ET
    2756 - Can Surface-Guided Radiation Therapy (SGRT) be Used to Monitor Intrafraction Motion of Patients Receiving Accelerated Partial Breast Irradiation (APBI)?
    Location: Hall C
    Presenter: Shifeng Chen, PhD – University of Maryland
  • 3:00 PM - 4:00 PM ET
    2757 - Safety of Concurrent Capecitabine and Radiotherapy in Breast Cancer Patients:A Real-World Analysis
    Location: Hall C
    Presenter: Chaofan Zhu
  • 5:00 PM - 6:00 PM ET
    2758 - Optimal Treatment Sequence for CDK4/6 Inhibitors and Radiation Combination Therapy in Estrogen Receptor-Positive Breast Cancer
    Location: Hall C
    Presenter: Reine Abou Zeidane, MD – Case Western Reserve School of Medicine
  • 5:00 PM - 6:00 PM ET
    2759 - Spatiotemporal Evaluation of the Early Inflammatory Response of the Gut to Radiation Using Non-Invasive In Vivo Redox Imaging
    Location: Hall C
    Presenter: Kosei Adachi, RT – Gifu University / Asahi University Hospital
  • 5:00 PM - 6:00 PM ET
    2760 - Role of ATP Binding Cassette Subfamily A Member 1 (ABCA1) in Renal Toxicity
    Location: Hall C
    Presenter: Anis Ahmad, PhD – University of Miami
  • 5:00 PM - 6:00 PM ET
    2761 - Sex as a Variable in Susceptibility to Radiation Induced Lung Injury and Macrophage Accumulation
    Location: Hall C
    Presenter: Heesu Ahn, PhD – National Institute of Health
  • 5:00 PM - 6:00 PM ET
    2762 - Modeling Twist1 Overexpression in a Pancreatic Ductal Adenocarcinoma Mouse Model
    Location: Hall C
    Presenter: Muhammad Ajmal Khan, PhD – University of Maryland School of Medicine
  • 5:00 PM - 6:00 PM ET
    2763 - Disparities in Completion of Patient-Reported Outcomes in Thoracic Radiation Oncology Patients
    Location: Hall C
    Presenter: Monzer Alatrach, MS, BS – MD Anderson Cancer Center
  • 5:00 PM - 6:00 PM ET
    2766 - Cannabis Assessment in Radiation Oncology - Evaluation Survey (CARES Study): Understanding Usage Patterns in Rural Underserved Radiation Cohort
    Location: Hall C
    Presenter: Evans Amoah, MD, MPH – University of Kentucky
  • 5:00 PM - 6:00 PM ET
    2767 - Counting the Cost: An Observational Study on Exploring Financial Toxicity and Its Determinants among Cancer Patients
    Location: Hall C
    Presenter: Yogesh Anap, MD, DNB – Kolhapur Cancer Centre
  • 5:00 PM - 6:00 PM ET
    2768 - Potential Utility of Interim PET CT as Predictive and Prognostic Marker is Locally Advanced Head and Neck Squamous Cell Carcinoma Patients Treated with Simultaneous Integrated Boost-IMRT- Can One Scan
    Location: Hall C
    Presenter: P Anuradha, MBBS – Health Care Global Limited
  • 5:00 PM - 6:00 PM ET
    2769 - Therapy Dogs Supported Radiotherapy in Cancer Patients Treated with MR Linac - Preliminary Results
    Location: Hall C
    Presenter: Banu Atalar, MD, RT – Acibadem Maslak Hospital
  • 5:00 PM - 6:00 PM ET
    2770 - Hypofractionated Radiation and T Cells in Oral Cancer on a Phase I Clinical Trial of Preoperative Radiation
    Location: Hall C
    Presenter: Musaddiq Awan, MD – Medical College of Wisconsin
  • 5:00 PM - 6:00 PM ET
    2771 - Comparison of Post Treatment Hematologic Changes between FLASH and Conventional Dose Rate Murine Brain Irradiation
    Location: Hall C
    Presenter: Khaled Aziz, MD, PhD – Johns Hopkins Radiation Oncology Kimmel Cancer Center
  • 5:00 PM - 6:00 PM ET
    2772 - Mechanisms of B-Cell Activity in Tumor Microenvironment
    Location: Hall C
    Presenter: Khaled Aziz, MD, PhD – Johns Hopkins Radiation Oncology Kimmel Cancer Center
  • 5:00 PM - 6:00 PM ET
    2773 - Ginsenoside Rg5 affects irradiation-induced lung fibrosis in mice via macrophage-mediated phagocytosis involving MERTK and PTX3
    Location: Hall C
    Presenter: Hansong Bai, MD, PhD – Georgetown - Lombardi Cancer Center and Georgetown Medical School
  • 5:00 PM - 6:00 PM ET
    2774 - Patient-reported outcomes from an App-delivered Yogic breathing when compared to mindfulness in post-radiation therapy in breast cancer survivors: a randomized controlled trial
    Location: Hall C
    Presenter: Sundar Balasubramanian, PhD – Medical University of South Carolina
  • 5:00 PM - 6:00 PM ET
    2775 - Radiation-Activated Prodrugs: An Investigation of Optimal Linker Chemistries and Radiation Parameters
    Location: Hall C
    Presenter: Leou Ismael Banla, MD, PhD – Harvard Radiation Oncology Program
  • 5:00 PM - 6:00 PM ET
    2777 - Radiation Enhances the Efficacy of HER2.28?/PD-L1.BB CAR-T Cells Against Triple-Negative Breast Cancer By Increased the Infiltration of CD8+ T Cells into Tumors
    Location: Hall C
    Presenter: Zhang Benxia – Sichuan University
  • 5:00 PM - 6:00 PM ET
    2778 - Impact of Survivorship Care Plans (SCPs) on Patients Perceptions of Information Provided from Diagnosis to Follow-Up in Breast Cancer Patients Treated at a Rural Community Cancer Center
    Location: Hall C
    Presenter: Paige Bordelon, BS, MPH – Vail Health Hospital
  • 5:00 PM - 6:00 PM ET
    2779 - Radiopharmaceutical Cell Surface Target Selection
    Location: Hall C
    Presenter: Scot Callahan, MD, PhD – UW Carbone Cancer Center
  • 5:00 PM - 6:00 PM ET
    2780 - The Association of Genetic Polymorphisms in the TNF-a Gene and Mucositis in Head and Neck Cancer Patients Treated with Combined Radiotherapy and Chemotherapy
    Location: Hall C
    Presenter: Ronaldo Cavalieri, MD, PhD – OncoBeda - Centro Integrado de Oncologia
  • 5:00 PM - 6:00 PM ET
    2781 - Investigating the Role of TNIK in the Pathogenesis of Lung Squamous Cell Carcinoma
    Location: Hall C
    Presenter: Jin Hee Chang, BS – University of Maryland School of Medicine
  • 5:00 PM - 6:00 PM ET
    2782 - Enrichment of Tumor-Associated Fragmentomic Features in Plasma with Focused Ultrasound-Enabled Liquid Biopsy in Glioma Patients
    Location: Hall C
    Presenter: Pradeep Chauhan, PhD – Mayo Clinic Rochester
  • 5:00 PM - 6:00 PM ET
    2783 - Impact of senolytic therapy on macrophages in radiation-induced skin fibrosis
    Location: Hall C
    Presenter: Eun Chung, PhD – National Institute of Health
  • 5:00 PM - 6:00 PM ET
    2784 - Highly-Multiplex Detection and Quantitation of Plasma Cell-Free Human Papillomavirus-16 DNA in Oropharyngeal Carcinoma
    Location: Hall C
    Presenter: Payton Clark, BS – Cleveland Clinic Foundation
  • 5:00 PM - 6:00 PM ET
    2785 - Autophagy is Required to the Regeneration of Salivary Gland after Radiation Injury
    Location: Hall C
    Presenter: Liu Dengqun, PhD – Sichuan Cancer Hospital
  • 5:00 PM - 6:00 PM ET
    2787 - MTA3 and Radiosensitivity of Non-Small Cell Lung Cancer through Enhancing Glutamine Synthetase-Mediated Cancer Stemness
    Location: Hall C
    Presenter: Liang Du, PhD – Chongqing University Cancer Hospital
  • 5:00 PM - 6:00 PM ET
    2788 - Bragg Peak Proton Radiotherapy Demonstrates Differing Radiobiological Phenotype on Phosphoproteomic Analysis
    Location: Hall C
    Presenter: Daniel Ebner, MD, MPH – Mayo Clinic
  • 5:00 PM - 6:00 PM ET
    2789 - Machine Learning-Based Prediction of Acute Care during Radiation Therapy Using the NCCN Distress Thermometer
    Location: Hall C
    Presenter: Jonathan Ejie, BS – University of California San Francisco
  • 5:00 PM - 6:00 PM ET
    2790 - Novel Role for SMPDL3b in Radiation Nephropathy
    Location: Hall C
    Presenter: Marina Francis, PhD – Stanford University School of Medicine
  • 5:00 PM - 6:00 PM ET
    2792 - Skeletal Muscle Loss after Short ADT Duration in Prostate Cancer Patients Treated with Radiation Therapy
    Location: Hall C
    Presenter: Ramesh Gadam, MD, MBBS – University of Kansas Medical Center
  • 5:00 PM - 6:00 PM ET
    2793 - Can Hyperthermia Treatment Restore Sensitivity to Anti-PDL1 Therapy in Immunological Cold Tumors? Lessons Learned from Preclinical Murine Models
    Location: Hall C
    Presenter: Guanyu Gong, PhD – Affiliated Zhongshan Hospital of Dalian University
  • 5:00 PM - 6:00 PM ET
    2794 - AP97-110 Combined with AZD6738 and Radiotherapy Sensitivity of Liver Cancer by Inhibiting XPO1 and ATR
    Location: Hall C
    Presenter: Liuyun Gong, MD, PhD – Xiamen University First Affiliated Hospital
  • 5:00 PM - 6:00 PM ET
    2795 - Unbiased Functional Genomics Screen Identifies Unique Therapeutic Vulnerabilities in Osimertinib-Resistant NSCLCs
    Location: Hall C
    Presenter: Alex Gooding, MD, PhD – Duke University
  • 5:00 PM - 6:00 PM ET
    2796 - Longitudinal T-Cell Receptor Analysis of Patients with Locally Advanced NSCLC Treated with Hypofractionated Chemoradiation and SABR Boost
    Location: Hall C
    Presenter: Jesus Juarez Casillas, MD, MS – UCLA
  • 5:00 PM - 6:00 PM ET
    2798 - SWItch/Sucrose NonFermentable Complex-Deficient Pulmonary Neoplasms: Clinicopathologic Characteristics and Outcomes to Radiotherapy and Immunotherapy
    Location: Hall C
    Presenter: Yu Gu, PhD
  • 5:00 PM - 6:00 PM ET
    2799 - A Feasibility Study of Using 64Cu-ATSM PET for Radiation Dose Painting Escalation in Locally Advanced Rectal Cancers
    Location: Hall C
    Presenter: Dorine de Jong, PhD – RefleXion
  • 5:00 PM - 6:00 PM ET
    2800 - Predictors of Clinically Significant Change on the Brief Fatigue Inventory
    Location: Hall C
    Presenter: Heather Gunn, PhD – Mayo Clinic
  • 5:00 PM - 6:00 PM ET
    2801 - Patient Reported Quality of Life after Chemoradiation for Esophageal Cancer: Analysis of Clinical and Dosimetric Predictors
    Location: Hall C
    Presenter: Nikita Gupta, BS – Georgetown University School of Medicine
  • 5:00 PM - 6:00 PM ET
    2802 - A Clinically-Mimetic Focal Bowel Irradiation Model to Assess Spatial Microbiome Perturbations after Duodenal Radiotherapy
    Location: Hall C
    Presenter: LeMoyne Habimana-Griffin, MD, PhD – Barnes Jewish Hospital
  • 5:00 PM - 6:00 PM ET
    2803 - Clonogenic Cell Survival Following In Vitro Irradiation Using Open vs. 2-Dimensional GRID Field Spatially Fractionated Radiotherapy of Murine Lymphoma, Breast and Renal Carcinoma
    Location: Hall C
    Presenter: Hye Ri Han, MD, MS – University of Southern California/Los Angeles General Medical Center
  • 5:00 PM - 6:00 PM ET
    2804 - Efficacy of Fas-4-1BB Immunomodulatory Fusion Proteins Engineered T-Cells in Applying to Targeted Pubic Neoantigen Immunotherapy Using Encapsulated Nanoparticles Directed by Radiation
    Location: Hall C
    Presenter: Satoshi Harada, MD, PhD – Iwate Medical University School of Medicine
  • 5:00 PM - 6:00 PM ET
    2805 - Mechanistic Study of the Anti-Tumor Effects of PRaG Therapy in a Mouse Colorectal Cancer Tumor Model
    Location: Hall C
    Presenter: Yaping He
  • 5:00 PM - 6:00 PM ET
    2806 - Radiation-Induced Pelvic Insufficiency Fractures and Sacro-Iliac Joint Optimisation in Pelvic External Beam Radiotherapy
    Location: Hall C
    Presenter: Emer Herlihy, MB – St. Luke's Radiation Oncology Network
  • 5:00 PM - 6:00 PM ET
    2807 - Assessing the Impact of Medical Physicists Education Consult in Radiotherapy Patients Care: A Pilot Study in Mexico
    Location: Hall C
    Presenter: Mariana Hernandez-Bojorquez, PhD, MS – American British Cowdray Medical Center
  • 5:00 PM - 6:00 PM ET
    2808 - The Mitigating Effects of Hyperbaric Oxygen Therapy on Radiation-Induced Neuronal Damage and Microglial Activation in Rats
    Location: Hall C
    Presenter: Sheng-Yow Ho, MD, MS – Chi Mei Medical Center
  • 5:00 PM - 6:00 PM ET
    2809 - Interferon-Dependent Cancer-Associated Fibroblasts Render the Responsiveness of Neoadjuvant Radiotherapy in Colorectal Cancer
    Location: Hall C
    Presenter: Lili Huang, MD, PhD – Fudan University Shanghai Cancer Center
  • 5:00 PM - 6:00 PM ET
    2810 - ITGA5 and Radioresistance through DNA Damage Repair in Esophageal Squamous Cell Carcinoma
    Location: Hall C
    Presenter: Xinyi Huang, MD
  • 5:00 PM - 6:00 PM ET
    2811 - Single-Cell Transcriptomic Analysis Deciphers Key Signatures Associated with Dynamic Evolution in Radiation-Induced Esophageal Injury
    Location: Hall C
    Presenter: Xinyi Huang, MD
  • 5:00 PM - 6:00 PM ET
    2812 - Inhibition of Tumor-Intrinsic BANF1 Sheds Light on Lung Cancer Radiotherapy
    Location: Hall C
  • 5:00 PM - 6:00 PM ET
    2813 - Dosimetric Predictors of Dysphonia in Long-Term Survivors of Locally Advanced Head and Neck Cancer Treated with Radiation Therapy
    Location: Hall C
    Presenter: Adam Hubler, MD – University of Alabama at Birmingham
  • 5:00 PM - 6:00 PM ET
    2814 - A Pilot Study to Detect Inflammatory Biomarkers of Pneumonitis in Exhaled Breath during Chemoradiotherapy for Stage III Non-Small Cell Lung Cancer
    Location: Hall C
    Presenter: Ryan Hughes, MD – Wake Forest University School of Medicine
  • 5:00 PM - 6:00 PM ET
    2815 - Urinary Quality of Life in Patients Treated with Prostate SBRT with Intra-Prostatic Boost
    Location: Hall C
    Presenter: Nisha Bhargava, BS – Beth Israel Deaconess Medical Center
  • 5:00 PM - 6:00 PM ET
    2816 - Patient Reported Outcomes and Patterns of Care after Proton Beam Therapy (PRT) for Gastrointestinal (GI) Cancers
    Location: Hall C
    Presenter: Michelle Iocolano, MD, MA – University of Pennsylvania
  • 5:00 PM - 6:00 PM ET
    2817 - Radiation Therapy Is Associated with Prefrailty in Breast Cancer Survivors Aged 40-65
    Location: Hall C
    Presenter: Brigitte Jia, BA – Vanderbilt University School of Medicine
  • 5:00 PM - 6:00 PM ET
    2818 - Effects and Mechanisms of Fractionated Radiotherapy Combined with CD47/PD-L1 Inhibitors in the Treatment of Esophageal Cancer
    Location: Hall C
    Presenter: Yang Jiao, MD, PhD – Medical College of Soochow University
  • 5:00 PM - 6:00 PM ET
    2819 - Prospective Longitudinal Patient Reported Outcomes (PROs) in Head and Neck Cancers (HNC) Treated with Chemoradiotherapy (CRT)
    Location: Hall C
    Presenter: Seema Kacker, MD, PhD – Johns Hopkins University
  • 5:00 PM - 6:00 PM ET
    2820 - Patient-Reported Xerostomia in Men Treated with Prostate Stereotactic Body Radiation Therapy: Implications for Future Radionuclide Therapy
    Location: Hall C
    Presenter: Diya Kallam, BA – George Washington University School of Medicine
  • 5:00 PM - 6:00 PM ET
    2821 - Financial Toxicity among Long Term Survivors of Prostate Cancer
    Location: Hall C
    Presenter: Katelyn Kane, MD – University of Kansas Medical Center
  • 5:00 PM - 6:00 PM ET
    2822 - Impact of Mental Health on Long-Term Patient-Reported Outcomes and Quality of Life after Head and Neck Radiation
    Location: Hall C
    Presenter: Ari Kassardjian, MD – City of Hope Comprehensive Cancer Center
  • 5:00 PM - 6:00 PM ET
    2823 - Patient-Derived Pancreatic Tumor Organoids as a Surrogate to Predict Radiation and Chemotherapy Response in Individual Patients: A Model for Precision Medicine
    Location: Hall C
    Presenter: Zachery Keepers, BS – University of Maryland School of Medicine
  • 5:00 PM - 6:00 PM ET
    2825 - The Impact of Neoadjuvant Relugolix on Multi-Dimensional Patient-Reported Fatigue
    Location: Hall C
    Presenter: Min Ji Koh – Georgetown University Hospital
  • 5:00 PM - 6:00 PM ET
    2826 - Combining Plk1 Inhibition and Radiation to Target Head and Neck Cancer
    Location: Hall C
    Presenter: Julianna Korns, BS – University of Cincinnati
  • 5:00 PM - 6:00 PM ET
    2827 - The Radiotherapy Information Gap in Survivorship Care Plans
    Location: Hall C
    Presenter: Ramez Kouzy, MD – MD Anderson Cancer Center
  • 5:00 PM - 6:00 PM ET
    2828 - Impact of Mindfulness in Patients with Prostate Cancer Treated with Radiation Therapy
    Location: Hall C
    Presenter: Bhupesh Parashar, MD, PhD – Zucker School of Medicine at Hofstra/Northwell
  • 5:00 PM - 6:00 PM ET
    2829 - The Role of RNA Stability in the Invasive Capacity of Radioresistant Triple Negative Breast Cancer
    Location: Hall C
    Presenter: Ayush Kumar, BS – UMass Chan Medical School / QARC
  • 5:00 PM - 6:00 PM ET
    2830 - Impact of TWIST1 Transactivation Domain towards Oncogene-Induced Senescence Suppression in Non-Small Cell Lung Cancer
    Location: Hall C
    Presenter: Audrey Lafargue, PhD – University of Maryland School of Medicine
  • 5:00 PM - 6:00 PM ET
    2831 - Survivorship Therapy after RadiOtherapy for head/Neck cancer: opportunities for Growth (STRONG)
    Location: Hall C
    Presenter: Alexis Larson, MSN, OCN, APRN – Northwestern Memorial Hospital
  • 5:00 PM - 6:00 PM ET
    2832 - Apolipoprotein E Mediates Radioresistance of Pancreatic Adenocarcinoma
    Location: Hall C
    Presenter: Talya Laufer, MD – Sidney Kimmel Cancer Center at Thomas Jefferson University
  • 5:00 PM - 6:00 PM ET
    2833 - Remotely Monitoring Patient-Reported Outcomes during and Immediately after Radiation Therapy
    Location: Hall C
    Presenter: Grace Lee, RT, MHSc – Princess Margaret Cancer Centre
  • 5:00 PM - 6:00 PM ET
    2834 - Prediction of Parotid Gland Changes in Radiation-Induced Oral Mucositis of Nasopharyngeal Carcinoma Based on Metabolism-Imaging Bimodal Omics
    Location: Hall C
    Presenter: Lei Ji, MD – The First Affiliated Hospital of Soochow University
  • 5:00 PM - 6:00 PM ET
    2835 - Exploration of the Effectiveness and Mechanism of Reversal of Radiotherapy Resistance in Head and Neck Squamous Cell Carcinoma by High-Energy X-Ray Based FLASH Radiotherapy
    Location: Hall C
    Presenter: Hong-Shuai Li
  • 5:00 PM - 6:00 PM ET
    2836 - Dual-Responsive Intelligent Nanosystem, Radiotherapy Resistance in Hypoxic Tumors, and Systemic Antitumor Immunity
    Location: Hall C
    Presenter: Ruidan Li
  • 5:00 PM - 6:00 PM ET
    2837 - Preliminary Study on Immunological Mechanism of Partial Stereotactic Ablative Boost Radiotherapy (P-SABR)
    Location: Hall C
    Presenter: Shanshi Li, PhD – Peking University First Hospital
  • 5:00 PM - 6:00 PM ET
    2838 - The Circadian Clock Gene, BMAL1, and Radiosensitization in Nasopharyngeal Carcinoma by Inhibiting the Epithelial-to-Mesenchymal Transition via the TGF-ß1/Smads/Snail1 axis
    Location: Hall C
    Presenter: Yuxin Li, MS
  • 5:00 PM - 6:00 PM ET
    2839 - SBRT-Induced Tumor Cell Necroptosis Facilitates Immune Evasion by Recruiting MDSCs via the Secretion of CXCL4
    Location: Hall C
    Presenter: Zhiyun Liao, MD – Chongqing University Cancer Hospital and Chongqing Cancer Institute
  • 5:00 PM - 6:00 PM ET
    2840 - Unraveling the Molecular Mechanisms of Radioresistance in Breast Cancer: A Transcriptomic and Proteomic Analysis
    Location: Hall C
    Presenter: Reine Abou Zeidane, MD – Case Western Reserve School of Medicine
  • 5:00 PM - 6:00 PM ET
    2841 - Verifying the Protective Effect of Miniaturized High-Energy X-Rays FLASH-RT Device and the Impact of Irradiation Fraction on Normal Tissues
    Location: Hall C
    Presenter: Binwei Lin, MD, MS – MianYang Central Hospital
  • 5:00 PM - 6:00 PM ET
    2842 - Unveiling the Intricate Interplay of ROS, Autophagy and p53 in Radioresistance of Hepatocellular Carcinoma
    Location: Hall C
    Presenter: Yu-Wei Lin, MD, PhD, MS – Kaohsiung Veterans General Hospital
  • 5:00 PM - 6:00 PM ET
    2843 - Study of Therapeutic Effect of Targeted IGF2BP2 Regulating SESN2 on Radiation-Induced Intestinal Injury
    Location: Hall C
    Presenter: Ruiqiu Zhu, MD, PhD – Soochow University
  • 5:00 PM - 6:00 PM ET
    2844 - Nucleic Acid Drug Targeting PEX5 for Sensitization to Radiotherapy in Hepatocellular Carcinoma
    Location: Hall C
    Presenter: Silin Liu
  • 5:00 PM - 6:00 PM ET
    2845 - Correlation between Primary Uptake of [18F]AlF-NOTA-FAPI-04 and Molecular Subtypes of Breast Cancer
    Location: Hall C
  • 5:00 PM - 6:00 PM ET
    2846 - Old Wine in a New Bottle: The Antimycotic Agent Oxiconazole and PRDX2-Mediated Ferroptosis in NSCLC
    Location: Hall C
    Presenter: Xu Liu – Shandong Cancer Hospital and Institute
  • 5:00 PM - 6:00 PM ET
    2847 - Economic Evaluation of Pediatric Cancer Survivors after Receiving Proton Radiotherapy Compared to Photon Radiotherapy: Real-World Data from 2010-2022
    Location: Hall C
    Presenter: Natalie Logie, MD – Tom Baker Cancer Centre / University of Calgary
  • 5:00 PM - 6:00 PM ET
    2848 - Pulsed vs. Single Shot Immune-Amplified 1Gy Miniscule Radiotherapy Synchronic with Immune-Check Point Inhibitors and SBRT in Disseminated Malignancies-Immuno-Rad(i-RT) Concept to Reprogram Microenviro
    Location: Hall C
    Presenter: G Lohith, MD – HCG
  • 5:00 PM - 6:00 PM ET
    2849 - Preoperative Radiosurgery on Early Breast Cancer Patients: Analysis of Tumor Genetic Background and Tumor Immune Microenvironment
    Location: Hall C
    Presenter: Mauro Loi, MD – Azienda Ospedaliera Universitaria Careggi
  • 5:00 PM - 6:00 PM ET
    2850 - EQFX - A Transformation of Previous Radiotherapy Dose to Stereotactic Fractionation
    Location: Hall C
  • 5:00 PM - 6:00 PM ET
    2851 - Identifying Potential Risk Factors for Increased Distress in Lung Cancer Patients Receiving Radiotherapy
    Location: Hall C
    Presenter: Bailey Loving, MD – Beaumont Health - Royal Oak
  • 5:00 PM - 6:00 PM ET
    2852 - Predictive Model of Family Resilience in Cervical Cancer Patients and Evaluation of Intervention Outcomes
    Location: Hall C
    Presenter: Jue Lu
  • 5:00 PM - 6:00 PM ET
    2853 - FLASH Radiotherapy Attenuated Indirect Radiation Damage of Mouse Liver Caused by Non-Target Effects
    Location: Hall C
    Presenter: Xingyu Lu, PhD – Southern Medical University
  • 5:00 PM - 6:00 PM ET
    2854 - CXCR4-Directed PET/CT may Distinguish Different Subtypes of Small Cell Lung Cancer
    Location: Hall C
    Presenter: Yuxi Luo, MD
  • 5:00 PM - 6:00 PM ET
    2855 - Combination of Radiotherapy and Complement-Mediated Immunotherapy
    Location: Hall C
    Presenter: Lixin Mai, MD – German Cancer Research Center (DKFZ)
  • 5:00 PM - 6:00 PM ET
    2856 - Biological Response Heterogeneity along the Proton Depth-Dose Curve
    Location: Hall C
    Presenter: Julian Malicki, PhD – Poznan University of Medical Sciences
  • 5:00 PM - 6:00 PM ET
    2857 - Photobiomodulation for the Prevention of Oral Mucositis in Patients Treated with Radiotherapy for Head and Neck Cancer
    Location: Hall C
  • 5:00 PM - 6:00 PM ET
    2858 - Applying a Portable Pocket Handheld Ultrasound Scanner to Monitor Tumor Volume in Preclinical Studies
    Location: Hall C
    Presenter: Stavros Melemenidis, PhD – Stanford University
  • 5:00 PM - 6:00 PM ET
    2859 - Spirituality and Religiousness as a Special Resource for Patients with Breast Cancer
    Location: Hall C
    Presenter: Oliver Micke, MD – Franzikus Hospital Bielefeld
  • 5:00 PM - 6:00 PM ET
    2860 - Multifunctional Ruthenium Covalent Organic Framework Sequentially Sensitize Radio-Radio-Dynamic-Immunotherapy against Cancer
    Location: Hall C
    Presenter: Yu Min, MD
  • 5:00 PM - 6:00 PM ET
    2861 - Conventional Radiotherapy may Potentiate Anti-Tumor Immunity in Patients with Meningioma
    Location: Hall C
    Presenter: Shubhendu Mishra, MD, MS – University of Minnesota Radiation Oncology Clinic University Campus
  • 5:00 PM - 6:00 PM ET
    2862 - Multi-Omics Analysis of Pulmonary Toxicity Induced by Radiotherapy and Combination of Immune Checkpoint Blockade and Radiotherapy
    Location: Hall C
    Presenter: You Mo
  • 5:00 PM - 6:00 PM ET
    2863 - Surprising Dose Dependent Sparing Effects of Fractionated FLASH Electrons in Experimental Radiation Induced Lung Fibrosis Model
    Location: Hall C
  • 5:00 PM - 6:00 PM ET
    2864 - Exploring Quality of Life, and Changes in Sexual Function and Urinary Symptoms in Patients Commencing Combined Hormonal Therapy with Abiraterone Acetate and a GnRH Agonist: A Prospective Study [CTRIAL
    Location: Hall C
    Presenter: Geraldine Murphy, MD, MB – Princess Margaret Cancer Center, University Health Network
  • 5:00 PM - 6:00 PM ET
    2865 - Focused CRISPR Activation-Based Screening to Identify Novel Targets of Chemoradiation Resistance in Pancreatic Cancer
    Location: Hall C
    Presenter: Sindhu Nair, PhD, DMD – City of Hope National Medical Center
  • 5:00 PM - 6:00 PM ET
    2866 - Genetic Profiling of Aggressive Prostate Cancer in Patients Undergoing High Dose Rate (HDR) Brachytherapy
    Location: Hall C
    Presenter: Beth Neilsen, MD, PhD – University of California Los Angeles
  • 5:00 PM - 6:00 PM ET
    2867 - Clinical Factors that Affect Patient-Reported Outcomes of Vaginal Stenosis after Pelvic Radiation Treatment for Cervical Cancer
    Location: Hall C
    Presenter: Anna Norman, BS – Baylor College of Medicine
  • 5:00 PM - 6:00 PM ET
    2868 - Changes in Systemic Immune Response and Its Dosimetric Correlates in Patients with Non-Small-Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy
    Location: Hall C
    Presenter: Zuzanna Nowicka, MD – Medical University of Lodz
  • 5:00 PM - 6:00 PM ET
    2869 - Development of a Multidisciplinary Sexual Health Program (MSHP): A Supportive Care Needs Assessment for Gynecological Cancer Survivors at a Community Hospital
    Location: Hall C
    Presenter: Joy Ogunmuyiwa, MD – New York Presbyterian
  • 5:00 PM - 6:00 PM ET
    2870 - Prediction of the Cell Killing Effect of Clinically-Used Mixed-LET Carbon Ions By Clustered Dsbs Volumes Using Super-Resolution Microscopy
    Location: Hall C
    Presenter: Takahiro Oike, MD, PhD – Gunma University
  • 5:00 PM - 6:00 PM ET
    2871 - Prostate Cancer Somatic Mutations and Outcomes of Salvage Radiation and Hormonal Therapy for Post-Prostatectomy Recurrence
    Location: Hall C
    Presenter: David Miyamoto, MD, PhD – Massachusetts General Hospital
  • 5:00 PM - 6:00 PM ET
    2872 - Non-Invasive Imaging of Acute Radiation-Induced Esophagitis by Targeting CXCR4
    Location: Hall C
    Presenter: Jinli Pei, PhD – Shandong Cancer Hospital and Institute
  • 5:00 PM - 6:00 PM ET
    2873 - Stereotactic Radiosurgery for Spinal Metastases with Gastrointestinal Histology vs. Other Radioresistant Histologies
    Location: Hall C
    Presenter: Dasha Klebaner, MD, BS, MPH – Stanford University Cancer Center
  • 5:00 PM - 6:00 PM ET
    2874 - Nanoparticles Reassembled Whole Cancer Cell Components, Detecting Tumor-Specific T Cells, and the Abscopal Effect
    Location: Hall C
    Presenter: Zhunyi Gao, BS
  • 5:00 PM - 6:00 PM ET
    2875 - Assessment of Sleep as an Individual Toxicity of Radiotherapy
    Location: Hall C
    Presenter: Vrushab Rao, MBBS, PDCR – Ruby Hall Clinic
  • 5:00 PM - 6:00 PM ET
    2876 - Comparison of Two Triple Therapy Regimens Involving RT and Anti-PD-1 in Tumor-Bearing Mice
    Location: Hall C
    Presenter: XI Rao, MD
  • 5:00 PM - 6:00 PM ET
    2877 - Evaluation of Financial Distress among Patients with Cancer in a Country with a Public Health Care System
    Location: Hall C
    Presenter: Ivica Ratosa, MD, PhD – Institute of Oncology Ljubljana
  • 5:00 PM - 6:00 PM ET
    2878 - Using Virtual Reality Technology to Improve Patient Anxiety and Reduce Opioids Use during HDR Brachytherapy Procedure for Patients with Gynecological Cancer
    Location: Hall C
    Presenter: Santanu Samanta, MD – University of Arkansas for Medical Sciences (UAMS)
  • 5:00 PM - 6:00 PM ET
    2879 - Mitophagy Promoting Fasting Diet Positioned Radiation Therapy for Harmonizing Dysregulated Cellular Energetics in Locally Advanced Non Metastatic Cancers: Conceptual Comparative Clinical Application S
    Location: Hall C
    Presenter: Krithikaa Sekar, MD, MBBS – Healthcare Global Enterprises Ltd.
  • 5:00 PM - 6:00 PM ET
    2880 - Reduced Gastrointestinal Toxicity with Rectal Spacing in Men Treated with Prostate Stereotactic Body Radiation Therapy and Supplemental Pelvic Intensity Modulated Radiation Therapy
    Location: Hall C
    Presenter: Vaibhav Sharma, MD – Medstar Georgetown University Hospital
  • 5:00 PM - 6:00 PM ET
    2881 - Biochemical and Biophysical Studies of Novel Small Molecules Targeting Proteasome Subunit Alpha Type-7 (PSMA7) for the Treatment of Glioblastoma
    Location: Hall C
    Presenter: Christian Showalter, PhD – The Ohio State University
  • 5:00 PM - 6:00 PM ET
    2882 - Systemic and Local Immunological Responses to Stereotactic Radiosurgery for HER2+ Breast Cancer Brain Metastasis
    Location: Hall C
    Presenter: Joseph Sia, MB, ChB, PhD, MBBS, FRANZCR – Peter MacCallum Cancer Centre
  • 5:00 PM - 6:00 PM ET
    2883 - ROA2233: A Prospective Study of Electronic Patient-Reported Outcomes Monitoring and Management
    Location: Hall C
    Presenter: Will Sperduto, MD – Mayo Clinic Arizona
  • 5:00 PM - 6:00 PM ET
    2884 - Ulinastatin and Radiation-Induced Brain Injury via Inhibition of Notch 1 in Mice
    Location: Hall C
    Presenter: Ning SU
  • 5:00 PM - 6:00 PM ET
    2885 - The transcriptional landscape of radiation-induced heart disease in mice using single-nucleus RNA sequencing
    Location: Hall C
    Presenter: Xi Su, MD – Shanghai Chest Hospital, Shanghai Jiao Tong University
  • 5:00 PM - 6:00 PM ET
    2887 - Financial Toxicities of Cancer Treatment for Patients Who Received Curative-Intent Radiation Therapy
    Location: Hall C
    Presenter: Elsa Sutton, MD – Mayo Clinic Rochester
  • 5:00 PM - 6:00 PM ET
    2888 - Characteristics and Trends in ESAS Scores of Radiation Oncology Patients Undergoing Outpatient Palliative Care Medicine at a Community Hospital
    Location: Hall C
    Presenter: Meghan Tahbaz, BA – University of South Florida College of Medicine
  • 5:00 PM - 6:00 PM ET
    2889 - Survey of Sexual Health Concerns among Patients with Treatment-Naïve Prostate Cancer
    Location: Hall C
    Presenter: Andrew Tam, MD – City of Hope National Medical Center
  • 5:00 PM - 6:00 PM ET
    2890 - Glucose-Enhanced Tumor Oxidative Phosphorylation and the Efficacy of Hypofractionated Radiotherapy through IFN-I Pathway
    Location: Hall C
    Presenter: Qingxu Tao, PhD
  • 5:00 PM - 6:00 PM ET
    2891 - Loss of Tumor Intrinsic RIPK1, Antitumor Immune Responses, and the Efficacy of PD-1 Blockade
    Location: Hall C
    Presenter: Feifei Teng, MD, PhD – Shandong Anti-Cancer Association
  • 5:00 PM - 6:00 PM ET
    2892 - Targeting A-to-I RNA Editing and Radiation-Induced CD8+ T Cell Dysfunction in Non-Small-Cell Lung Cancer
    Location: Hall C
    Presenter: Zengfu Zhang, MD – Shandong Cancer Hospital and Institute
  • 5:00 PM - 6:00 PM ET
    2893 - Irradiation-Induced Intestinal Injury and Mucus Secretion from Goblet Cells by Activating Endoplasmic Reticulum Stress
    Location: Hall C
    Presenter: Ye Tian, MD – The Second Affiliated Hospital of Soochow University
  • 5:00 PM - 6:00 PM ET
    2894 - Partial Kidney Radiation Modeling for the Effect of Kidney Dysfunction in Pediatric Cancer
    Location: Hall C
    Presenter: Federico Ticona, MD, International Medical Graduate – Huntsman Cancer Institute at the University of Utah
  • 5:00 PM - 6:00 PM ET
    2895 - Implementing ePROMs in a Safety-Net Radiation Oncology Clinic: Pre- and Post-COVID-19
    Location: Hall C
    Presenter: Rebecca N. Tsai, MS, BS – Boston University School of Medicine
  • 5:00 PM - 6:00 PM ET
    2896 - First Steps toward Prevention of Patchy Alopecia Following Linac Based Fractionated Stereotactic Radiotherapy (fSRT) for Arteriovenous Malformation(AVM): A Retrospective, Single Institutional Experien
    Location: Hall C
    Presenter: Birjoo Vaishnav, PhD, DABR – Mayo Clinic College of Medicine and Science Rochester
  • 5:00 PM - 6:00 PM ET
    2898 - Prospective Longitudinal Study of Quality of Life, Brain Substructure Atrophy, and Neurocognitive Outcomes in Children Following Proton Therapy for Brain Tumors
    Location: Hall C
    Presenter: Katherine Von Werne, MSN – Miami Cancer Institute: Baptist Health South Florida
  • 5:00 PM - 6:00 PM ET
    2899 - Remodeling the Tumor-Immune Microenvironment by Radiotherapy and Anti-BTLA Blockade Enhance Anti-PD-L1 Efficacy
    Location: Hall C
    Presenter: Bin Wang, MS
  • 5:00 PM - 6:00 PM ET
    2900 - The Correlation of Mean Dose Rate with Electron FLASH Effect in Mouse Skin and Associated Metabonomic Profile Analysis
    Location: Hall C
    Presenter: Chen Wang, MD
  • 5:00 PM - 6:00 PM ET
    2901 - CDC42 Inhibitor and the Radiosensitivity of Non-Small Cell Lung Cancer by Restraining BRCA1-Mediated DNA Damage Repair
    Location: Hall C
    Presenter: Fei Wang, PhD
  • 5:00 PM - 6:00 PM ET
    2902 - Targeting Solid Stress to Improve Radiotherapeutic Efficacy via Chromatin Modulation
    Location: Hall C
    Presenter: Jin Wang
  • 5:00 PM - 6:00 PM ET
    2903 - Radiation Combined with Anti-PD-1 Inhibitor and Myocardial Injury via NLRP3 Inflammasome in Mice
    Location: Hall C
    Presenter: Jun Wang, PhD
  • 5:00 PM - 6:00 PM ET
    2904 - Radiation Enhances PD-L1 in Cardiomyocytes: Implications for Combined Radiation and Anti-Programmed Death-1 (PD-1) Antibody-Induced Myocardial Injury
    Location: Hall C
    Presenter: Jun Wang, MD, PhD – Fourth Hospital of Hebei Medical University
  • 5:00 PM - 6:00 PM ET
    2905 - NLRP3 Inflammasome Activation by mtROS in Cardiomyocytes and Radiation Induced Acute Myocardial Injury
    Location: Hall C
    Presenter: Jun Wang, MD, PhD – Fourth Hospital of Hebei Medical University
  • 5:00 PM - 6:00 PM ET
    2906 - Adding a PPARa Agonist Enhances T Cell-Mediated Effects of RT in Combination with Anti-PD-1
    Location: Hall C
    Presenter: Meidan Wang, PhD – University of Freiburg
  • 5:00 PM - 6:00 PM ET
    2907 - Targeting O-GlcNAcylation Rearrangement and Radiotherapy Sensitivity in NSCLC via the Axis of OGA/HCF1/ RAD18
    Location: Hall C
    Presenter: Zengfu Zhang, MD – Shandong Cancer Hospital and Institute
  • 5:00 PM - 6:00 PM ET
    2908 - Enhancing Cancer Therapy: Synergistic Effects of Withaferin A and Ionizing Radiation on Lung Cancer Cells
    Location: Hall C
    Presenter: Yu-Jen Wang, MD, PhD – Fu Jen Catholic University Hospital
  • 5:00 PM - 6:00 PM ET
    2909 - Targeting Ferroptosis to Prevent Radiation-induced Intestinal Injury
    Location: Hall C
    Presenter: Yun-Long Wang
  • 5:00 PM - 6:00 PM ET
    2910 - Radiobiology Population Modeling of Intestinal Stem Cells and Intestinal Epithelial Cells to Predict Radiation Induced Toxicity
    Location: Hall C
    Presenter: William Watkins, PhD – City of Hope National Medical Center
  • 5:00 PM - 6:00 PM ET
    2911 - PD-L1 Coexpression Gene Analysis in Esophageal Squamous Cell Carcinoma, B2M, and the Prognosis and Infiltration of Immune Cells
    Location: Hall C
    Presenter: Yahong Wei, MD
  • 5:00 PM - 6:00 PM ET
    2912 - Regulation Mechanism of Radioresistance in Cervical Cancer Mediated By Trfs through SLC31A1-Dependent Cuproptosis
    Location: Hall C
    Presenter: Ning Wu
  • 5:00 PM - 6:00 PM ET
    2913 - Effects of FLASH Irradiation on Liver Metabolomics in Mice Subjected to Partial-Liver Irradiation
    Location: Hall C
    Presenter: Dehuan Xie, MD – Guangdong Provincial People's Hospital
  • 5:00 PM - 6:00 PM ET
    2914 - Lycopene and Radiotherapy Induced Radiation Enteritis Regarding the SAA3-Mediated Inflammatory Factor Storm
    Location: Hall C
    Presenter: Xin Chen, MBBS – Cancer Hospital Chinese Academy of Medical Sciences
  • 5:00 PM - 6:00 PM ET
    2915 - Radiation-Induced Antigen Expression Benefits Tumor Uptake of ICAM1 Antibody-Drug Conjugates
    Location: Hall C
    Presenter: Yun Xing, BS – Tianjin University
  • 5:00 PM - 6:00 PM ET
    2916 - m6A Modification of Zbp1 and Tfam in Regulates Radiation-Induced Skin Fibrosis via Senescence-Associated Secretory Phenotype (SASP)
    Location: Hall C
    Presenter: Jiahe Xu, MS
  • 5:00 PM - 6:00 PM ET
    2917 - Preclinical Evaluation and Pilot Clinical Study of [18F]AlF-NOTA-QHY-04 for PET Imaging of CXCR4 Expression in Hematologic Malignancy and Solid Tumors
    Location: Hall C
    Presenter: Shengnan Xu, MD
  • 5:00 PM - 6:00 PM ET
    2918 - Patient Related Outcomes for Gynecologic Radiation Oncology (PRO-GRO)
    Location: Hall C
    Presenter: Victoria Xu, BS – University of North Carolina at Chapel Hill
  • 5:00 PM - 6:00 PM ET
    2919 - Inhibition of Tumor Intrinsic SLC16A3, Radiotherapy Efficacy, and Tumor Immune Microenvironment Improvement
    Location: Hall C
    Presenter: Xin Xu, MD, PhD
  • 5:00 PM - 6:00 PM ET
    2920 - Effect of NLRP3 Inhibition on Immune Priming and Abscopal Responses Induced by Radiotherapy Combined with Immunotherapy in Colon Cancer
    Location: Hall C
    Presenter: Peipei Yan
  • 5:00 PM - 6:00 PM ET
    2921 - Investigating Tumor Response and Efficacy of 5-Aminolevulinic Acid-Mediated Radiodynamic Therapy: Utilizing Photon Irradiation, Activation of Photosensitizer and Catalytic Effects
    Location: Hall C
    Presenter: Dae-Myoung Yang, PhD – Fox Chase Cancer Center
  • 5:00 PM - 6:00 PM ET
    2922 - Fanconi Anemia Complementation Group I (FANCI) Mediates Oncogenic BRAF-Driven Radiation Resistance in Thyroid Cancer
    Location: Hall C
    Presenter: Linlin Yang, MD, PhD – City of Hope Comprehensive Cancer Center
  • 5:00 PM - 6:00 PM ET
    2923 - Enhancing Histological Image Analysis and Automation through Unsupervised Attention-Guided Deep Learning for Robust Stain Normalization in H&E-Stained Images
    Location: Hall C
    Presenter: Zi Yang, PhD – Stanford University
  • 5:00 PM - 6:00 PM ET
    2924 - Molecular Profiling of Skin Cells Identifies Distinct Cellular Signatures in Radiation-Induced Skin Injury across Various Stages
    Location: Hall C
    Presenter: Zengfu Zhang, MD – Shandong Cancer Hospital and Institute
  • 5:00 PM - 6:00 PM ET
    2925 - Effects of Lactobacillus rhamnosus DY801 on Acute Bowel Injury During Radiochemotherapy: Regulation of Methionine Metabolism and Th17 Cells
    Location: Hall C
    Presenter: Lu Yu, MD, PhD
  • 5:00 PM - 6:00 PM ET
    2926 - ILT4, Immunosuppression, and Resistance to Radioimmunotherapy (iRT) in Non-Small Cell Lung Cancer (NSCLC) through Recruiting SHP2 to Induce Mitochondrial Oxidative Stress-Mediated Tumor-Associated Mac
    Location: Hall C
    Presenter: Meng Yuan, MS
  • 5:00 PM - 6:00 PM ET
    2927 - The Role and Mechanism of Fatty Acids in Radiation-Induced Skin Injury
    Location: Hall C
    Presenter: Xiao Yuji
  • 5:00 PM - 6:00 PM ET
    2928 - The Impact of EBF1 on Radiation Sensitivity of NSCLC via GS-Induced Enhancement of Cancer Stemness
    Location: Hall C
    Presenter: Siwei Zeng
  • 5:00 PM - 6:00 PM ET
    2929 - CXCL3 Signaling and the Tumor-Promoting Activity of Cancer-Associated Fibroblasts in Esophageal Squamous Cell Carcinoma
    Location: Hall C
    Presenter: Hongfang Zhang, PhD – Hangzhou Cancer Hospital
  • 5:00 PM - 6:00 PM ET
    2930 - Impacts of Combining Anti-PD-1 Immunotherapy and PLDR on the Tumour Immune Microenvironment in a Murine Lung Cancer Model
    Location: Hall C
    Presenter: Peng Zhang, MD – Sichuan Cancer Hospital and Institute
  • 5:00 PM - 6:00 PM ET
    2931 - Fibulin-5 Secreted by Cancer-Associated Fibroblasts and Radioresistance in Non-Small Cell Lung Cancer
    Location: Hall C
    Presenter: Ran Zhang, PhD – Shandong Cancer Hospital Affiliated to Shandong First Medical University
  • 5:00 PM - 6:00 PM ET
    2932 - SET, Non-Small Cell Lung Cancer Cell Stemness, and Radio-Immunotherapy Resistance Via JAK/STAT-TGF ß Signaling Network
    Location: Hall C
  • 5:00 PM - 6:00 PM ET
    2933 - Radiotherapy Plus Aurora A Kinase Inhibitor Reshape the Immune Microenvironment and Potentiate Anti-Tumor Responses
    Location: Hall C
    Presenter: Weitao Wen, PhD – Shandong Cancer Hospital Affiliated to Shandong First Medical University
  • 5:00 PM - 6:00 PM ET
    2934 - Mechanistic of RBM3 Regulating Rad51 Alternative Splicing Mediated DNA Damage Repair Promoting Radioresistance of Nasopharyngeal Carcinoma
    Location: Hall C
    Presenter: Lina Zhao, MD, PhD – Xijing Hospital, Air Force Medical University
  • 5:00 PM - 6:00 PM ET
    2935 - Anti-Tumor Responses of Icaritin Combined Radiotherapy Treatment and Its Immune Mechanisms
    Location: Hall C
    Presenter: Yue Zhao, MD, PhD – China
  • 5:00 PM - 6:00 PM ET
    2936 - Radiotherapy Combined with Repurposed Old Drugs Effects on Polyploid Giant Triple Negative Breast Cancer Cells
    Location: Hall C
    Presenter: Mengli Zhou, MD – ShenZhen Cancer Hospital
  • 5:00 PM - 6:00 PM ET
    2937 - Short Chain Fatty Acids for Prevention and Treatment of Radiation Lung Injury
    Location: Hall C
  • 5:00 PM - 6:00 PM ET
    2938 - FLASH-RT has Advantages over Conventional-RT in Promoting DC Homing to Lymph Nodes and T Cell Activation
    Location: Hall C
    Presenter: Ziqi Zhou, MD – Peking Union Medical College Hospital
  • 5:00 PM - 6:00 PM ET
    2939 - Nanocarrier-Based Immunotherapy Combined with Radiation Therapy to Enhance the Radiosensitivity of Colorectal Cancer
    Location: Hall C
    Presenter: Ziwei Zhu – Sichuan Cancer Hospital
  • 5:00 PM - 6:00 PM ET
    2940 - Reflexology as an Integrative Approach to Improve Stress, Energy, and Pain in Women Receiving Radiotherapy for Breast Cancer
    Location: Hall C
    Presenter: Heather Zinkin, MD – Northwell Health
  • 5:00 PM - 6:00 PM ET
    2941 - Toxicity with Contemporary Radiotherapy in Inflammatory Bowel Disease Patients Treated for Pelvic Malignancies
    Location: Hall C
    Presenter: Julia ZInkin
  • 5:00 PM - 6:00 PM ET
    2942 - Toward a Clinical Trial in the Human Liver: Effect of Intralesional Diffusing Alpha Emitters Radiation Therapy on Orthotopic Murine Liver Colorectal Metastasis Growth, Healthy Liver Tissue and Immune
    Location: Hall C
    Presenter: Ronen Segal, PhD, MBA – Alpha TAU Medical Ltd.
  • 5:00 PM - 6:00 PM ET
    2943 - COST-FACIT Analysis of Cancer Patients Treated with Radiotherapy in a Publicly Funded Healthcare System in One Country
    Location: Hall C
    Presenter: Barbara Helena Zobec Logar, MD, PhD, MS – Institute of Oncology Ljubljana, Faculty of Medicine, University of Ljubljana
  • 5:00 PM - 6:00 PM ET
    2974 - Salvage Radiotherapy in Isolated Locoregional Recurrence of Pancreatic Adenocarcinoma Post-Radical Surgical Resection: Prudent or Pointless? A Retrospective Comparative Analysis
    Location: Hall C
    Presenter: Aruz Mesci, MD, PhD – Princess Margaret Cancer Center, University Health Network
  • 5:00 PM - 6:00 PM ET
    3186 - Is there an association between the location of the dominant intraprostatic lesion and biochemical/clinical failure following treatment with LDR prostate brachytherapy?
    Location: Hall C
    Presenter: Suneil Jain, MB, PhD – Queen's University Belfast